# Chapter 14: Delusional Disorder

# Chapter 5: The Biological and Neurological Basis of Delusional Disorder

## Introduction

Delusional Disorder (DD) represents a unique and often enigmatic entity within the spectrum of psychotic disorders. It is defined primarily by the presence of one or more nonbizarre delusions that persist for at least one month, in the relative absence of other prominent psychopathology (Manschreck, 1996; Ramasamy et al., 2014). Unlike schizophrenia, which typically involves a broader disintegration of thought processes, emotional responsiveness, and contact with reality (Gur & Johnson, 2006; Katon & Ries, 1983), individuals with Delusional Disorder often maintain relatively normal functioning and behavior outside the direct influence of their delusional beliefs (Manschreck, 1996; Sherchan & Joshi, 2015). The delusions themselves are considered "nonbizarre" in that they pertain to situations that could conceivably occur in real life, such as being followed, having a disease, or being loved from a distance (Manschreck, 1996; Talasman & Dolfi, 2018).

From a biological and neurological perspective, Delusional Disorder remains one of the less-understood psychotic conditions, particularly when compared to the extensive body of research on schizophrenia and bipolar disorder (Manschreck, 1996; Munro, 1999). While the nosological boundaries of schizophrenia itself are a subject of ongoing debate (van Praag, 1978; Heinrichs, 1993), its study has yielded a wealth of neurobiological hypotheses concerning dopamine dysregulation, neurodevelopmental abnormalities, and genetic predispositions (Braitman & Bustillo, 2020; Heckers, 2009; Suzuki, 2019). The biological investigation of Delusional Disorder has been far more limited, often relying on inferences from related conditions and the mechanisms of action of effective treatments (Manschreck, 1996).

This chapter aims to provide a comprehensive overview of the current understanding of the biological and neurological underpinnings of Delusional Disorder, synthesized exclusively from the available research literature. The exploration of its biological basis is critical, as it moves beyond purely descriptive psychopathology to investigate the fundamental brain mechanisms that give rise to the formation and maintenance of fixed, false beliefs. Such an understanding is essential for refining diagnostic categories, developing more targeted and effective treatments, and ultimately improving the prognosis for individuals affected by this challenging condition.

We will examine the evidence implicating various neurotransmitter systems, particularly dopamine, based on pharmacological treatment responses (Buckley & Foster, 2014; Ereshefsky et al., 1990). We will explore neuroanatomical findings, drawing parallels from studies of other psychotic and neurodegenerative disorders to hypothesize about the neural circuits that might be uniquely dysfunctional in Delusional Disorder (Kopelman et al., 1995; Goodwin, 1997). The chapter will also delve into genetic and molecular factors, considering the possibility of a shared vulnerability with other conditions on the psychotic and affective spectrums (Munro, 1999; Kendler, 1982). Furthermore, we will consider the disorder from a neurodevelopmental perspective, contrasting its typical middle-to-late adult onset with the earlier emergence of schizophrenia (Manschreck, 1996; Yassa & Suranyi-Cadotte, 1993). Finally, the biological heterogeneity of the disorder, as suggested by its distinct clinical subtypes (e.g., somatic, persecutory, erotomanic), will be discussed in the context of potential underlying biological diversity (Manschreck, 1996; Lepping et al., 2015). Throughout this chapter, while drawing on knowledge from related disorders, we will maintain a critical perspective, acknowledging the significant gaps that remain in our direct, evidence-based understanding of the neurobiology of Delusional Disorder itself.

## Neurobiological Systems

The investigation into the neurobiological systems underlying Delusional Disorder is largely inferential, relying heavily on the mechanisms of action of psychopharmacological agents and analogies drawn from more extensively studied psychotic disorders like schizophrenia (Manschreck, 1996; Munro, 1999). The core disturbance—the fixed, incorrigible delusion—points toward dysfunction in the brain's systems for belief formation, salience attribution, and reality testing (Giotakos, 2017).

### Neurotransmitter Systems and Neuropharmacology

The most compelling evidence for the biological basis of Delusional Disorder comes from its response to pharmacotherapy, which points squarely at the involvement of central neurotransmitter systems, most notably dopamine (Manschreck, 1996; Buckley & Foster, 2014).

**The Dopamine Hypothesis:** The dopamine hypothesis of psychosis, originally formulated for schizophrenia, posits that an excess of dopaminergic activity, particularly in mesolimbic pathways, underlies the development of positive psychotic symptoms like delusions and hallucinations (Ereshefsky et al., 1990; Braitman & Bustillo, 2020). The primary treatment for Delusional Disorder involves antipsychotic medications, which are effective because of their action as dopamine receptor antagonists, specifically at the D2 receptor subtype (Buckley & Foster, 2014; McEvoy et al., 2020). This therapeutic response provides strong, albeit indirect, evidence that dopaminergic dysregulation is a key pathophysiological mechanism in Delusional Disorder (Manschreck, 1996; Katon & Ries, 1983).

Unlike schizophrenia, where dopamine hyperactivity is thought to be widespread and associated with a range of positive, negative, and cognitive symptoms (MacDonald & Demro, 2023; Tandon et al., 2008b), the dysfunction in Delusional Disorder may be more circumscribed. The relative preservation of personality and cognitive function outside the delusional system (Manschreck, 1996) suggests a more localized or subtle dopaminergic imbalance, perhaps confined to specific circuits involved in belief evaluation and salience attribution, rather than a global brain dysfunction (Arbuck, 2022; van Praag, 1978). Drug-induced psychoses, particularly those caused by stimulants like amphetamines and cocaine which increase dopamine release, can produce paranoid delusions that closely mimic the persecutory type of Delusional Disorder, further strengthening the link between dopamine and delusional psychopathology (Avellaneda Ojeda et al., 2023; Henning et al., 2019; Hansell, 1975).

**Serotonin and Atypical Antipsychotics:** The development of second-generation, or "atypical," antipsychotics introduced the role of other neurotransmitter systems, particularly serotonin (Moore et al., 1992). These agents combine D2 receptor antagonism with actions at various serotonin receptors, which is thought to contribute to their efficacy and potentially better side-effect profile (Groisman & Seminatore, 2003; Ereshefsky et al., 1990). The use of these agents in Delusional Disorder implies that serotonergic systems may also be involved, perhaps in modulating dopaminergic pathways or contributing to the affective and cognitive components of the delusional belief system (Willner, 1984). Furthermore, the frequent comorbidity of Delusional Disorder with depressive symptoms (Manschreck, 1996; Martí Garnica et al., 2017) and the occasional use of Selective Serotonin Reuptake Inhibitors (SSRIs) as adjunctive treatments (Casey & Bailey, 2011) suggest a role for serotonin in the broader clinical picture, even if it is not central to delusion formation itself (Yadav, 2005; Kennedy, 2008). The complex interplay between dopamine and serotonin systems remains a critical area for research in understanding the full neurochemical basis of delusional states (Van Praag et al., 2004).

**Glutamate and Other Systems:** The glutamate hypothesis of schizophrenia, which posits hypofunction of the N-methyl-D-aspartate (NMDA) receptor, has gained considerable traction, particularly in explaining cognitive and negative symptoms (Rico, 2012; Uno & Coyle, 2019). While there is no direct evidence from the provided literature linking glutamate to Delusional Disorder, its role in neuroplasticity and the modulation of dopamine and serotonin systems makes it a plausible candidate for investigation (Mizuno et al., 2019). Given that delusions can be seen as a disorder of belief formation and cognitive appraisal (Giotakos, 2017), dysfunction in the glutamatergic systems that underpin these higher-order cognitive functions could be relevant. Similarly, other neurotransmitters like norepinephrine and GABA, which are implicated in mood and anxiety disorders (Fiar et al., 2012; Praško et al., 2009), may play a role in the affective coloring and anxiety associated with delusional beliefs, especially in persecutory or jealous types (Manschreck, 1996). The observation that benzodiazepines, which act on GABA-A receptors, can be used to manage acute agitation associated with psychosis further supports a role for GABAergic systems in the overall clinical presentation (Battaglia et al., 2007; Levy, 1996).

In summary, the neuropharmacological evidence strongly supports a central role for dopamine dysregulation in the pathophysiology of Delusional Disorder. However, the clinical complexity of the disorder, its subtypes, and its comorbidities suggest that a multi-neurotransmitter model, involving serotonin, and potentially glutamate and GABA, is likely necessary to fully explain the biological underpinnings of this condition.

## Genetic and Molecular Basis

The etiology of Delusional Disorder, like most psychiatric conditions, is believed to involve a complex interplay of genetic and environmental factors (Manschreck, 1996). While research specifically targeting the genetics of Delusional Disorder is sparse compared to schizophrenia or bipolar disorder, existing clinical observations and family studies provide important clues about its heritability and potential molecular underpinnings.

### Genetic Factors and Heritability

Familial transmission of Delusional Disorder has been suspected based on clinical reports, suggesting that the condition may aggregate in families (Manschreck, 1996). Studies comparing Delusional Disorder with schizophrenia and affective illness have noted that while its demographic profile is distinct, it shares some familial risk patterns with these major psychoses (Kendler, 1982). For instance, an increased incidence of paranoid or schizoid personality traits has been observed in the relatives of individuals with Delusional Disorder, which may represent a subclinical or attenuated expression of a shared genetic vulnerability (Yassa & Suranyi-Cadotte, 1993).

The concept of a "paranoid spectrum" or "schizophrenia spectrum" suggests a group of illnesses with phenomenological and potentially etiological relationships (Munro, 1999; Heckers, 2009). Delusional Disorder is often considered part of this spectrum (Reichenberg & Seligman, 2016). Genetic research in schizophrenia has established it as a highly heritable, polygenic illness (Braitman & Bustillo, 2020; Stringer et al., 2015), and it is plausible that some of the hundreds of common genetic variants conferring risk for schizophrenia may also contribute to the risk for Delusional Disorder (Braitman & Bustillo, 2020). Similarly, the high rates of comorbid mood disorders in patients with Delusional Disorder (Manschreck, 1996; Martí Garnica et al., 2017) and the increased familial rates of affective illness (Ryall, 1989) suggest a potential genetic overlap with bipolar disorder and major depression, which are also known to be highly heritable (Winokur, 1970; Adetunji et al., 2007). The interaction of multiple psychosis-related genes may give rise to atypical phenomenological presentations (Braconi, 1976), which could account for the distinct clinical profile of Delusional Disorder compared to schizophrenia.

### Molecular Mechanisms

Direct investigation into the molecular mechanisms of Delusional Disorder is exceptionally limited. Therefore, hypotheses must be extrapolated from our understanding of psychosis in general and the action of psychotropic medications.

**Dopaminergic Pathways:** As discussed previously, the efficacy of dopamine D2 receptor antagonists is the cornerstone of treatment for Delusional Disorder (Manschreck, 1996). This strongly implies that the molecular pathology involves the D2 receptor pathway (Buckley & Foster, 2014; Braitman & Bustillo, 2020). Genetic variations in genes encoding for the D2 receptor, dopamine transporters, or enzymes involved in dopamine metabolism (e.g., COMT) are plausible candidates for conferring susceptibility (Arbuck, 2022). Research in schizophrenia has pointed to elevated presynaptic striatal dopamine synthesis and release as a key abnormality (Suzuki, 2019), and it is conceivable that a similar, perhaps more localized, molecular dysfunction is present in Delusional Disorder. The experience of paranoid delusions in states of dopamine excess, such as with stimulant abuse, further supports this molecular link (Avellaneda Ojeda et al., 2023; Henning et al., 2019).

**Serotonergic and Other Pathways:** The involvement of serotonin is suggested by the efficacy of atypical antipsychotics which have actions at 5-HT receptors (Moore et al., 1992). Molecular abnormalities in serotonin transporter genes or specific serotonin receptor subtypes could contribute to vulnerability, particularly in patients with comorbid depressive or anxious features (Casey & Bailey, 2011; Van Praag et al., 2004). Research into depression has highlighted the role of serotonin systems in mood regulation (Sahakian & Morein‐Zamir, 2011), and a dysfunction in these pathways could interact with dopaminergic abnormalities to shape the specific presentation of Delusional Disorder.

**Neurodevelopmental and Neurodegenerative Pathways:** Schizophrenia is often conceptualized as a neurodevelopmental disorder involving aberrant brain wiring and synaptic pruning during adolescence (Fernández-Egea & Jones, 2023; Sommer & Arango, 2017). The later onset of Delusional Disorder (Manschreck, 1996; Kendler, 1982) might suggest different underlying molecular processes, possibly related to aging, neuroinflammation, or subtle neurodegenerative changes (Yassa & Suranyi-Cadotte, 1993; Palmer et al., 2001). For instance, molecular pathways associated with oxidative stress or mitochondrial dysfunction, which are implicated in aging and neurodegeneration, could contribute to the late-life emergence of delusional psychopathology (Sommer & Arango, 2017). The presence of delusional symptoms in established neurodegenerative diseases like Alzheimer's disease and dementia with Lewy bodies points to shared molecular vulnerabilities in protein aggregation, neuronal integrity, and synaptic function that could be relevant to primary Delusional Disorder (Byrne, 1996; Devanand, 1999; Berrios & Brook, 1985).

In conclusion, the genetic and molecular basis of Delusional Disorder is largely uncharted territory. However, evidence from family studies and research into related psychotic and affective disorders suggests a heritable component. The molecular mechanisms likely involve dysregulation of dopaminergic pathways, with potential contributions from serotonergic and other systems, possibly arising from a different developmental or degenerative trajectory than that seen in schizophrenia.

## Brain Structure and Function

The study of brain structure and function in Delusional Disorder is in its infancy, with a significant lack of dedicated neuroimaging and neuropathological research. Consequently, much of our understanding is based on theoretical models of delusion formation and extrapolations from related conditions, such as schizophrenia, organic delusional syndromes, and dementias that present with psychosis (Kopelman et al., 1995; Yassa & Suranyi-Cadotte, 1993).

### Neuroimaging Findings

While no definitive structural or functional neuroimaging signature for Delusional Disorder has been established, research in related disorders provides a roadmap for potential areas of investigation.

**Structural Imaging:** In contrast to schizophrenia, where subtle but consistent structural brain abnormalities like ventricular enlargement and reductions in cortical gray matter volume are frequently reported (Opjordsmoen, 1991; Premkumar & Sharma, 2005; Braitman & Bustillo, 2020), individuals with Delusional Disorder are often described as having grossly normal brain imaging (Manschreck, 1996). This apparent lack of widespread structural change is consistent with the absence of global cognitive decline and the preservation of personality and social functioning that distinguishes Delusional Disorder from schizophrenia (Manschreck, 1996; Katon & Ries, 1983).

However, the absence of gross abnormalities does not preclude more subtle, localized changes. Studies of late-onset schizophrenia and delusional disorders have sometimes implicated structural changes in conferring vulnerability to psychosis in later life (Yassa & Suranyi-Cadotte, 1993; Palmer et al., 2001). Given the clinical phenomenology of delusions, which involve complex cognitive and affective processes, key areas of interest for future structural imaging studies would include the frontal lobes, temporal lobes, and limbic structures such as the hippocampus and amygdala (Goodwin, 1997; Mahieux, 2003). For example, a case study of De Clérambault's syndrome (erotomanic delusions) noted the presence of moderate anterograde memory impairment, suggesting potential hippocampal dysfunction, though it did not find evidence of frontal lobe dysfunction on executive tasks (Kopelman et al., 1995). The presence of somatic delusions in some patients might point towards abnormalities in parietal regions involved in body representation (Spence, 2006). Neurological conditions such as stroke, tumors, or traumatic brain injury can occasionally present with delusional syndromes, underscoring the role of specific brain lesions in generating fixed false beliefs (Thomas, 2007; Pontius, 1993; Talasman et al., 2019).

**Functional Imaging:** Functional neuroimaging techniques, such as SPECT and PET, offer a window into the brain's activity. While largely unapplied to Delusional Disorder, studies in schizophrenia have revealed patterns of abnormal brain activation, most notably "hypofrontality," or reduced prefrontal cortex activity, especially during executive tasks (Goodwin, 1997; Premkumar & Sharma, 2005). This is thought to relate to the cognitive and negative symptoms of schizophrenia (Karyakina et al., 2021; Strassnig & Harvey, 2019). Given that patients with Delusional Disorder generally lack these deficits (Manschreck, 1996), their pattern of frontal activation might be expected to be different.

One functional imaging study in a patient with dissociative amnesia, another disorder involving psychological mechanisms, found decreased perfusion in the left medial temporal lobe (Kurita et al., 2004), highlighting the potential for functional imaging to reveal abnormalities even in the absence of structural lesions. It is hypothesized that in Delusional Disorder, there may be hyperactivity in limbic and paralimbic regions (involved in emotion and salience) coupled with dysfunction in prefrontal cortical areas responsible for belief evaluation and reality testing (Giotakos, 2017; Fletcher, 2003). This could lead to the misattribution of salience to neutral events and a failure to correct the resulting false belief.

### Brain Regions, Neural Circuits, and Functional Connectivity

Based on the clinical picture of Delusional Disorder and knowledge from related fields, a "two-factor" neuropsychological model of delusion formation is often proposed. This model suggests that two distinct cognitive deficits are necessary: one that leads to the initial formation of the strange belief, and a second that prevents the rejection of this belief (Giotakos, 2017). This maps onto a potential neural circuit dysfunction involving at least two interconnected systems.

**Limbic and Paralimbic Systems:** The limbic system, including the amygdala and hippocampus, is crucial for emotional processing and memory (Mahieux, 2003). The ventral striatum is central to reward and salience attribution. Hyperactivity or dysregulation within these regions, possibly driven by the dopamine system, could lead to the aberrant assignment of significance to irrelevant stimuli, forming the seed of a delusional belief (Suzuki, 2019). This aligns with the often emotionally charged nature of delusions (e.g., fear in persecutory types, desire in erotomanic types) (Manschreck, 1996). Psychosis associated with temporal lobe epilepsy provides a compelling model for how dysfunction in these regions can generate complex psychotic experiences (Flor-Henry, 1972; McKenna et al., 1985; Nadkarni et al., 2007).

**Prefrontal Cortex:** The prefrontal cortex (PFC), particularly the dorsolateral PFC and orbitofrontal cortex, is responsible for executive functions, including reasoning, belief evaluation, and inhibiting prepotent responses (Goodwin, 1997; Johnson-Greene, 1999). A dysfunction in this system could explain the second factor in delusion formation: the failure to critically evaluate and reject a bizarre or unlikely belief (Giotakos, 2017). Patients with frontal lobe damage can exhibit confabulation and impaired insight, which share features with delusional thinking (Kopelman et al., 1995; Soriano Pérez et al., 2005). The circumscribed nature of the delusion in DD, with intact reasoning in other domains, suggests that this PFC dysfunction might be subtle or only active in relation to the specific delusional content, rather than representing a global executive deficit (Manschreck, 1996).

**Fronto-Striatal-Limbic Circuits:** The prevailing view is that delusions arise not from a single brain region but from disordered connectivity within large-scale neural circuits (Fernández-Egea & Jones, 2023). The most relevant circuits likely involve connections between the prefrontal cortex, the temporal lobes (including the hippocampus and amygdala), and the striatum (Goodwin, 1997; Arango, 2011). A breakdown in the normal, coordinated activity within these networks could simultaneously lead to aberrant salience generation (limbic/striatal) and impaired belief evaluation (frontal), creating a self-sustaining delusional system (Fletcher, 2003). This model could explain why the core psychopathology of Delusional Disorder is so focused, while other cognitive and social functions, subserved by different or intact circuits, remain preserved.

## Developmental Neurobiology

The developmental trajectory of Delusional Disorder appears to be markedly different from that of schizophrenia, providing important clues about its potential etiology and underlying neurobiology. While schizophrenia is increasingly understood as a neurodevelopmental disorder with roots in early life (Fernández-Egea & Jones, 2023; Groisman & Seminatore, 2003), Delusional Disorder typically emerges in middle or late adulthood, often in individuals with no prior psychiatric history (Manschreck, 1996; Kendler, 1982).

### Onset and Critical Periods

The onset of Delusional Disorder is usually in middle or late adulthood, with an average age of onset around 40 years or later (Manschreck, 1996; Kendler, 1982). This contrasts sharply with the peak onset of schizophrenia in late adolescence and early adulthood (Groisman & Seminatore, 2003; Kane, 1996), a critical period for brain maturation processes like synaptic pruning and myelination (Sommer & Arango, 2017). The late onset of Delusional Disorder suggests that early neurodevelopmental insults, such as those implicated in schizophrenia (e.g., perinatal complications, maternal infection), are less likely to be primary causal factors (Groisman & Seminatore, 2003; Murray et al., 1995).

Instead, the emergence of delusions in later life may point to processes related to brain aging, cumulative environmental stressors, or a "second hit" that acts upon a pre-existing but latent vulnerability (Palmer et al., 2001; Yassa & Suranyi-Cadotte, 1993). The concept of "late-onset schizophrenia" or "very-late-onset schizophrenia-like psychosis" provides a potential parallel, where psychotic symptoms first appear after age 40 or 60 (Yassa & Suranyi-Cadotte, 1993; Binbay et al., 2012). These late-onset psychoses are often distinguished from early-onset schizophrenia by better premorbid functioning, a lower prevalence of negative symptoms, and a different pattern of neurobiological findings, features that are also characteristic of Delusional Disorder (Yassa & Suranyi-Cadotte, 1993; Kendler, 1982).

### Premorbid Functioning and Prodromal Phase

Individuals who develop Delusional Disorder typically have normal premorbid functioning and personality, although some reports suggest a higher incidence of paranoid or schizoid personality traits (Manschreck, 1996; Yassa & Suranyi-Cadotte, 1993). This stands in contrast to the often-impaired premorbid social and academic functioning seen in a significant proportion of individuals who later develop schizophrenia (Groisman & Seminatore, 2003; Häfner, 2002).

The prodromal phase of schizophrenia can last for several years and is characterized by non-specific symptoms like social withdrawal, dysphoric mood, sleep disturbance, and a decline in functioning (Häfner, 2002; Triki et al., 2012; Davidson & Weiser, 2004). While a prodromal period may exist in Delusional Disorder, it is less well-defined. The onset can be insidious, with the delusional belief developing gradually from a state of heightened suspicion or preoccupation (Manschreck, 1996). In some cases, the onset is more abrupt, often following a significant life stressor (Casey & Bailey, 2011). This suggests that the neurobiological processes leading to the manifest illness may be different; rather than a long, slow deviation from a normal developmental trajectory, Delusional Disorder might represent a more acute decompensation of specific neural systems in a previously well-functioning brain.

### The Role of Aging and Neurological Comorbidity

The late onset of Delusional Disorder raises questions about the role of age-related changes in the brain. Normal aging is associated with subtle changes in brain structure and function, including some decline in frontal lobe executive functions and alterations in neurotransmitter systems (Goodwin, 1997). It is plausible that these age-related changes could lower the threshold for developing psychosis in vulnerable individuals.

Furthermore, Delusional Disorder may arise in the context of other neurological or medical conditions that become more prevalent with age (Manschreck, 1996). Delusions are a known feature of various dementias, such as Alzheimer's disease and dementia with Lewy bodies (Berrios & Brook, 1985; Devanand, 1999; Byrne, 1996), and can also occur secondary to stroke or other structural brain lesions (Thomas, 2007; Talasman et al., 2019). The presence of delusions in these conditions demonstrates that neurodegenerative and vascular processes can directly disrupt the brain circuits responsible for reality testing. This suggests that some cases diagnosed as primary Delusional Disorder may, in fact, be the initial presentation of an underlying, slowly progressing neurodegenerative or cerebrovascular process (Yassa & Suranyi-Cadotte, 1993; Palmer et al., 2001). For example, sensory deficits, such as hearing impairment, which are common in older adults, have been proposed as a risk factor for the development of paranoid delusions, possibly by reducing sensory input and promoting misinterpretation of the environment (Macleod, 1877).

In summary, the developmental neurobiology of Delusional Disorder appears distinct from that of schizophrenia. Its late onset, generally normal premorbid history, and association with aging and neurological comorbidity suggest a pathophysiology that is less dependent on early developmental disruption and more related to processes that affect the mature or aging brain.

## Treatment Mechanisms

The biological basis of treatments for Delusional Disorder provides further, albeit indirect, evidence for the underlying neurobiology of the condition itself. As with pathophysiology, our understanding is primarily derived from the known mechanisms of action of pharmacological agents used to treat psychosis and comorbid mood symptoms (Manschreck, 1996; Oral, 2005).

### Neuropharmacological Interventions

The mainstay of treatment for Delusional Disorder is antipsychotic medication (Manschreck, 1996). The therapeutic effect of these agents is believed to stem from their modulation of key neurotransmitter systems, primarily dopamine.

**Dopamine Receptor Antagonism:** First-generation ("typical") antipsychotics exert their therapeutic effect primarily through the blockade of dopamine D2 receptors in mesolimbic pathways (Buckley & Foster, 2014; Braitman & Bustillo, 2020). By reducing dopaminergic neurotransmission, these drugs are thought to dampen the aberrant salience and reinforcement signals that contribute to the formation and maintenance of delusions (Suzuki, 2019). The clinical response in Delusional Disorder to these agents reinforces the central role of dopamine hyperactivity in the disorder's pathophysiology (Katon & Ries, 1983). However, these medications are also associated with a high risk of extrapyramidal symptoms (EPS), such as parkinsonism and tardive dyskinesia, due to their action on dopamine pathways in the basal ganglia (Holloman & Marder, 1997; Waddington & Youssef, 1986).

**Serotonin-Dopamine Antagonism:** Second-generation ("atypical") antipsychotics, such as risperidone, olanzapine, and clozapine, have a more complex mechanism of action, combining D2 antagonism with potent effects on various serotonin receptors, particularly 5-HT2A antagonism (Moore et al., 1992; Ereshefsky et al., 1990). This dual action is thought to contribute to their efficacy against a broader range of symptoms and a lower propensity to cause EPS compared to typical agents (Groisman & Seminatore, 2003). In Delusional Disorder, this mechanism may be beneficial not only for the core delusion but also for associated affective symptoms (Martí Garnica et al., 2017). The efficacy of these agents suggests that an imbalance in the serotonin-dopamine system, rather than a simple excess of dopamine, may be at play (Van Praag et al., 2004; Willner, 1984). Clozapine, in particular, has unique efficacy in treatment-resistant psychosis, which may relate to its relatively weak D2 blockade and its broad receptor profile, though its use is limited by serious potential side effects (Moore et al., 1992; Ballon & Lieberman, 2010).

**Adjunctive Pharmacotherapy:** Given the high rate of comorbid depressive symptoms in Delusional Disorder (Manschreck, 1996; Martí Garnica et al., 2017), antidepressants are sometimes used as an adjunctive treatment (Casey & Bailey, 2011). Selective serotonin reuptake inhibitors (SSRIs) are a common choice. Their mechanism involves increasing the synaptic availability of serotonin, which can alleviate depressive mood, anxiety, and potentially obsessive preoccupations related to the delusion (Pitchot et al., 2007; Casey & Bailey, 2011). The positive response to SSRIs in some patients highlights the contribution of the serotonergic system to the overall clinical picture, even if it is not the primary driver of the delusion itself. Benzodiazepines may also be used on a short-term basis to manage acute agitation or severe anxiety, acting via enhancement of GABAergic inhibition to produce a calming effect (Battaglia et al., 2007; Levy, 1996).

### Neuroplasticity and Psychosocial Interventions

While pharmacotherapy is the primary biological intervention, psychosocial treatments, including certain forms of psychotherapy, are a crucial component of management (Manschreck, 1996). Although these are not biological treatments per se, their effectiveness likely relies on inducing neuroplastic changes in the brain circuits that mediate belief, emotion, and behavior.

Cognitive-behavioral therapy (CBT), for example, aims to help patients identify and challenge the evidence for their delusional beliefs and develop alternative, less distressing explanations (Casey & Bailey, 2011). From a neurobiological standpoint, this process can be conceptualized as a "top-down" modulation of brain activity. By engaging prefrontal cortical systems involved in reasoning and cognitive control, CBT may help strengthen the brain's capacity to regulate the bottom-up, aberrant salience signals arising from limbic or striatal regions (Fletcher, 2003). This repeated cognitive effort may induce long-term synaptic changes, effectively "rewiring" the maladaptive circuits that sustain the delusion.

Supportive psychotherapy and psychoeducation help patients cope with the consequences of their delusion and improve treatment adherence (Manschreck, 1996). By reducing psychosocial stress, these interventions can modulate the activity of the hypothalamic-pituitary-adrenal (HPA) axis and other neuroendocrine stress response systems (Van Praag et al., 2004; Juruena, 2012). Since stress can exacerbate psychotic and mood symptoms (House, 1987; Casey & Bailey, 2011), therapies that mitigate stress may have a stabilizing effect on the underlying neurobiology, reducing the risk of relapse and improving overall functioning.

In essence, an integrated treatment approach combines the "bottom-up" neurochemical modulation of pharmacotherapy with the "top-down" circuit-level modulation of psychosocial interventions. This dual approach addresses both the aberrant neurobiological state and the maladaptive cognitive and behavioral patterns that emerge from it, offering the most comprehensive strategy for managing Delusional Disorder.

## Future Directions

The biological and neurological understanding of Delusional Disorder lags significantly behind that of other major psychotic disorders, such as schizophrenia and bipolar disorder. This gap is largely due to its lower prevalence, the challenges in recruiting patient cohorts for research, and its historical conceptualization as a "minor" psychosis (Kendler, 1982; Manschreck, 1996). The existing literature, as reviewed in this chapter, is built largely on clinical observation, pharmacological inference, and analogy to other conditions. Future research must move toward direct investigation of the neurobiology of Delusional Disorder to validate current hypotheses and uncover novel mechanisms.

**Advanced Neuroimaging:** There is a critical need for systematic structural and functional neuroimaging studies in well-characterized cohorts of patients with Delusional Disorder. High-resolution structural MRI could identify subtle volumetric or cortical thickness abnormalities in brain regions hypothesized to be involved, such as the prefrontal cortex, temporal lobes, and limbic structures (Goodwin, 1997; Premkumar & Sharma, 2005). Diffusion Tensor Imaging (DTI) could assess the integrity of white matter tracts connecting these regions, providing direct evidence for the "disconnection" hypotheses of delusion formation (Fernández-Egea & Jones, 2023). Functional MRI (fMRI) and PET studies are needed to examine brain activation patterns during tasks that probe belief evaluation, salience processing, and emotional regulation, which could reveal the specific functional circuit abnormalities underlying delusional thought (Fletcher, 2003; Suzuki, 2019).

**Genetics and Molecular Biology:** Large-scale genetic studies, including genome-wide association studies (GWAS), are required to identify susceptibility genes for Delusional Disorder. Such studies have been transformative in schizophrenia research (Stringer et al., 2015) and could clarify the genetic relationship between Delusional Disorder, schizophrenia, and affective disorders (Munro, 1999; Winokur, 1970). Investigating whether risk alleles for schizophrenia or bipolar disorder are also overrepresented in Delusional Disorder would provide strong evidence for a shared genetic diathesis. Furthermore, molecular studies examining neurotransmitter receptor densities, transporter function, and second messenger systems in post-mortem tissue or through advanced PET imaging could directly test the dopamine and serotonin hypotheses (Braitman & Bustillo, 2020; Van Praag et al., 2004).

**Neurophysiology and Cognitive Neuroscience:** Electroencephalography (EEG) and event-related potentials (ERPs) are powerful tools for examining the temporal dynamics of neural processing with high precision. Studies using these methods could investigate potential deficits in early-stage sensory processing, attentional modulation (e.g., P50 gating, P300 amplitude), and error monitoring (e.g., error-related negativity), which are known to be abnormal in schizophrenia (Drury et al., 1985; Arango et al., 2000). The specific profile of neurophysiological abnormalities in Delusional Disorder could help differentiate it from other psychoses and illuminate the precise cognitive processes that are disrupted. For example, the study by Kopelman et al. (1995) suggested that delusional memory may arise without the executive dysfunction often seen in organic confabulation, pointing to a potentially distinct neurocognitive mechanism.

**Longitudinal and Subtype-Specific Research:** Delusional Disorder is not a monolithic entity (Manschreck, 1996). Future research must account for its clinical heterogeneity. Comparing the neurobiology of different delusional subtypes (e.g., persecutory, somatic, jealous, erotomanic) could reveal whether these distinct clinical presentations correspond to different underlying neural substrates (Lepping et al., 2015; Talasman & Dolfi, 2018). For instance, are somatic delusions associated with specific dysfunctions in the somatosensory cortex or insula (Spence, 2006)? Do erotomanic delusions involve specific abnormalities in reward or social cognition circuits (Kopelman et al., 1995)?

Furthermore, longitudinal studies are essential. Tracking individuals from the onset of the disorder through its course can help differentiate state-related biological changes from stable trait markers of vulnerability. This is particularly important given the disorder's late onset, which raises questions about the interaction between genetic predisposition and age-related neurobiological changes (Palmer et al., 2001; Yassa & Suranyi-Cadotte, 1993). Such studies could clarify whether Delusional Disorder is a static condition or if it is associated with progressive brain changes over time, as has been debated in schizophrenia (Zipursky et al., 2012).

By pursuing these avenues of research, the field can move from a largely inferential understanding of Delusional Disorder to one grounded in direct neurobiological evidence. This will be indispensable for developing novel, mechanism-based treatments and for refining a nosology that more accurately reflects the underlying brain pathology.

## Conclusion

Delusional Disorder, characterized by persistent, nonbizarre delusions in the absence of the global functional and cognitive deterioration typical of schizophrenia, remains a significant challenge for clinical neuroscience (Manschreck, 1996; Ramasamy et al., 2014). The biological and neurological foundations of this condition are not yet clearly delineated, and our current understanding is constructed primarily from a mosaic of clinical psychopharmacology, case studies, and analogies drawn from more extensively researched psychotic and affective disorders (Munro, 1999; Kendler, 1982).

The most robust line of evidence points to a central role for the dopamine system in the pathophysiology of Delusional Disorder. The consistent, albeit sometimes partial, response of delusional symptoms to antipsychotic medications that antagonize dopamine D2 receptors provides a strong pharmacological argument for dopaminergic dysregulation as a core biological substrate (Buckley & Foster, 2014; Braitman & Bustillo, 2020). However, the circumscribed nature of the psychopathology in Delusional Disorder suggests that this dysregulation may be more localized or subtle than the widespread dysfunction hypothesized in schizophrenia (Manschreck, 1996; Katon & Ries, 1983). The efficacy of atypical antipsychotics further implicates the serotonin system, suggesting a more complex interplay of monoaminergic systems in modulating belief formation and emotional salience (Moore et al., 1992; Van Praag et al., 2004).

From a neuroanatomical perspective, the absence of gross structural brain abnormalities in many patients with Delusional Disorder aligns with their preserved global cognitive function (Manschreck, 1996). It is hypothesized that the disorder arises not from widespread atrophy, but from a more subtle dysfunction within specific large-scale neural circuits, particularly those linking the prefrontal cortex, temporal lobes, and subcortical limbic and striatal structures (Goodwin, 1997; Fletcher, 2003). A disruption in this fronto-limbic-striatal network could plausibly account for the dual deficit thought to underlie delusions: an aberrant assignment of salience to perceptions and thoughts, coupled with a failure of higher-order belief evaluation systems to correct these false interpretations (Giotakos, 2017).

The genetic basis of Delusional Disorder remains largely unexplored, but familial aggregation and clinical overlap with both schizophrenia and mood disorders suggest a potential shared genetic vulnerability (Kendler, 1982; Manschreck, 1996; Ryall, 1989). The disorder's typical onset in middle-to-late adulthood distinguishes it from the classic neurodevelopmental model of schizophrenia, pointing instead toward a pathophysiology that may involve interactions between latent genetic predispositions and the neurobiological processes of aging, cumulative stress, or subtle, late-emerging neuropathology (Yassa & Suranyi-Cadotte, 1993; Palmer et al., 2001).

Ultimately, Delusional Disorder likely represents a heterogeneous group of conditions that converge on a final common pathway of fixed, false belief. The distinct clinical subtypes—persecutory, somatic, jealous, grandiose, and erotomanic—may well be underpinned by different patterns of neurobiological dysfunction (Manschreck, 1996; Lepping et al., 2015). Progress in understanding this complex disorder will depend on dedicated future research that employs advanced neuroimaging, genetic, and neurophysiological techniques to study well-defined patient populations. Such work is essential to move beyond the current framework of inference and analogy, and to develop a robust, evidence-based neurobiological model of delusional thought that can guide the development of more precise and effective treatments.

## References

1. Adams, C. E., Wilson, P., Gilbody, S., Bagnall, A., & Lewis, R. (2000). Drug treatments for schizophrenia. Quality in Health Care. https://doi.org/10.1136/qhc.9.1.73
2. Adebayo, K., Gureje, O., & Nuhu, T. (2012). Obsessive-compulsive Disorder: A Spectrum or Prodrome of Schizophrenia? A Case Report and Literature Review.. Deleted Journal.
3. Adetunji, B., Matthews, M., Basil, B., & Oyemade, A. (2007). "Bipolar Family". The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0211e
4. Adler, G. (2006). Diagnostik der Demenz. Notfall & Hausarztmedizin (Notfallmedizin). https://doi.org/10.1055/s-2006-959110
5. Agarwal, K., Yadav, A. K., Verma, P., & Kaur, B. (2021). DYSTHYMIA AND it’s HOMOEOPATHIC MANAGEMENT. Journal of Emerging Technologies and Innovative Research.
6. Aguilar‐Valles, A. (2011). IDENTIFICACIÓN DE FACTORES GENÉTICOS EN LA ETIOLOGÍA DE LA ESQUIZOFRENIA Identification of Genetic Factors in the Etiology of Schizophrenia. Acta Biológica Colombiana.
7. Ajayi, O., Esangbedo, A., Lawal, A. A., Olanrewaju, A. O., Ojo, T. O., & Talabi, O. (2023). Moral Injury, Trance and Possession State or a Schizophrenic Illness. a Case report. BJPsych Open. https://doi.org/10.1192/bjo.2023.359
8. Al-Balawi, T., Al-Greeshah, F., & Khan, S. (2003). Management of status epilepticus.. PubMed.
9. Al-Mashkur, N. M., Hansen, C. M., Perczynski, L., & Pankiewicz, M. (2020). Differential diagnoses of dissociative amnesia in a younger woman. Ugeskrift for Læger.
10. Alarcón, R. D. (2016). El diagnóstico precoz de las depresiones de la vejez. Deleted Journal. https://doi.org/10.15581/021.12.6450
11. Albrecht, S., Leineweber, C., Ojajärvi, A., Oksanen, T., Kecklund, G., & Härmä, M. (2020). Association of work-time control with sickness absence due to musculoskeletal and mental disorders: An occupational cohort study. Journal of Occupational Health. https://doi.org/10.1002/1348-9585.12181
12. Alcoverro-Fortuny, Ò., Nicolau, A. L. P., Ruiz, G. H., & Pedraza, A. (2003). [Thought disorders in obsessive-compulsive disorder].. PubMed.
13. Alexandre, S., Misery, L., Dutray, S., Chastaing, M., Consoli, S.-M., Audra, H., Bauer, D., Bertolus, S., Callot, V., Cardinaud, F., Corrin, E., Féton-Danou, N., Malet, R., Touboul, S., & Consoli, S. (2007). Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-0266
14. Alloy, L. B., & Abramson, L. Y. (2010). Cyclothymic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0249
15. Alsaadi, A. R., Asiri, W. A., & Almaqbali, M. (2020). Obsessive-Compulsive Disorder as a Part of Prodromal Schizophrenia. Clinical Psychiatry.
16. Altamura, A., Cattaneo, E., Pozzoli, S., Bassetti, R., & Sacco, L. (2006). Inquadramento diagnostico e gestione farmacologica della depressione senile Assessment and pharmacological management of elderly depression.
17. Alvarado, R., Shilling, S., & Jorquera, M. J. (2015). Uso de la Intervención Critical Time Intervention en personas con primer episodio de psicosis. Revista de la Facultad de Ciencias Médicas de Córdoba. https://doi.org/10.31053/1853.0605.v72.n4.13845
18. Al‐Melh, M. A., Farghal, M., & Abdelall, N. (2022). Psychosis as a Possible Prodrome of Multiple Sclerosis: A Case Report. BJPsych Open. https://doi.org/10.1192/bjo.2022.76
19. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
20. An, T., Ra, Y., Han, C., Kim, H., Lee, K.-S., & Bae, H. (2015). Clinical Correlates of Subtype and Severity in Patients with Delirium. Journal of Korean Neuropsychiatric Association. https://doi.org/10.4306/jknpa.2015.54.4.489
21. Andrews, G., Brugha, T., Thase, M. E., Duffy, F. F., Rucci, P., & Slade, T. (2007). Dimensionality and the category of major depressive episode. International Journal of Methods in Psychiatric Research. https://doi.org/10.1002/mpr.216
22. Angelica, O. J. X. (2005). Reconocimiento de expresiones emocionales y depresión en pacientes con ictus: un estudio longitudinal comparativo.
23. Arango, C. (2011). Neurobiological susbtrates in deficit and non deficit schizophrenia. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)73772-5
24. Arango, C., Kirkpatrick, B., & Buchanan, R. W. (2000). Neurological Signs and the Heterogeneity of Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.560
25. Arata, L., & Paz, M. D. L. (2019). Comorbilidad en el trastorno por déficit de atención e hiperactividad. Importancia en el diagnóstico diferencial.
26. Arbuck, D. M. (2022). Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 1). Current psychiatry. https://doi.org/10.12788/cp.0242
27. Arredondo-Aldana, K., Mera-Posligua, M. J., & Alencastro, J. A. P. (2021). Trastorno Depresivo Persistente y Trastornos de Ansiedad Generalizada Proveniente de un Estrés Post Traumático Crónico: Presentación de un Caso Clínico. Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. https://doi.org/10.46296/gt.v4i8edesp.0027
28. Assis, A. P. S. D., Pereira, D. A., Santos, P. S. M., Rosa, A. L. G., Orsini, M., & Catharino, A. M. D. S. (2022). Somatosomesthetic hallucinations in parietal lobe seizures: A case report. International Journal of Case Reports and Images. https://doi.org/10.5348/101356z01as2022cr
29. Avari, J., Yuen, G. S., AbdelMalak, B., Mahgoub, N., Kalayam, B., & Alexopoulos, G. S. (2014). Assessment and Management of Late-Life Depression. Psychiatric Annals. https://doi.org/10.3928/00485713-20140306-04
30. Awara, M. A., Green, J. T., & Elnenaei, M. O. (2022). The psychiatric and neurological interface of multiple sclerosis: case report and literature review. European Journal of Medical Case Reports. https://doi.org/10.24911/ejmcr/173-1651693131
31. Ayala, L., Gómez‐Revuelta, M., Requena, C. M., Acilu, E. S. D. A. G. D., Olivares, O. P., Ruíz, M. J., Morales, N. N., Martin, M., Zufiaurre, M. L., Hernández, B., Itoiz, A. A., Peña, M., & González‐Pinto, A. (2017). Clozapine: Since the very beginning?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.1402
32. Baandrup, L., Jennum, P., Lublin, H., & Glenthøj, B. (2012). Treatment options for residual insomnia in schizophrenia. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12016
33. Badrin, S., Mohamad, N., Yunus, N. A., & Zulkifli, M. M. (2017). A Brief Psychotic Episode with Depressive Symptoms in Silent Right Frontal Lobe Infarct. Korean Journal of Family Medicine. https://doi.org/10.4082/kjfm.2017.38.6.380
34. Baldaçara, L., Ramos, A., & Castaldelli-Maia, J. M. (2023). Managing drug-induced psychosis. International Review of Psychiatry. https://doi.org/10.1080/09540261.2023.2261544
35. Balhara, Y. P. S., Mohan, I., Sagar, R., & Chawla, J. (2006). Chronic mania: An unexpectidly long episode?. Indian Journal of Medical Sciences. https://doi.org/10.4103/0019-5359.25681
36. Ballerini, A., & Ballerini, A. (2000). Dysphoria: A Key for ‘Understanding’ Delusion?. Psychopathology. https://doi.org/10.1159/000029146
37. Ballon, J. S., & Lieberman, J. A. (2010). Advances in the Management of Treatment- Resistant Schizophrenia. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/foc.8.4.foc475
38. Bano, S., Das, S., Mazumder, A., Das, S., & Aman, S. (2015). The Landau Kleffner Syndrome.
39. Barnes, T. R. E., & Paton, C. (2011). Do antidepressants improve negative symptoms in schizophrenia?. BMJ. https://doi.org/10.1136/bmj.d3371
40. Barnhill, J. W., Hilty, D. M., Gitlin, M., Oquendo, M. A., Cosgrove, V. E., Suppes, T., Findling, R. L., Ferrando, S. J., Daniels, J., Jones, M., & Swartz, H. A. (2023). Bipolar and Related Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615375295.jb03
41. Barnhill, J. W., Loewenstein, R. J., Simeon, D., & Lewis‐Fernández, R. (2023). Dissociative Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615375295.jb08
42. Bartoli, F. (2023). The Diagnostic Concept of Unipolar Mania. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/nmd.0000000000001704
43. Baser, S., Leichliter, T., Whiting, D., & Oh, M. (2023). Movement Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781316338513.021
44. Bass, C., & Wade, D. T. (2018). Malingering and factitious disorder. Practical Neurology. https://doi.org/10.1136/practneurol-2018-001950
45. Bassiri, A., Holden, J., & Wong, M. (1995). A Case of Fulminant Human Immunodeficiency Virus Dementia. Clinical Infectious Diseases. https://doi.org/10.1093/clinids/21.5.1313
46. Battaglia, J., Robinson, D. G., & Citrome, L. (2007). The Treatment of Acute Agitation in Schizophrenia. CNS Spectrums. https://doi.org/10.1017/s1092852900026146
47. Baup, N. (2007). [Clinical aspects of obsessive-compulsive disorder].. PubMed.
48. Becker, M. A., Weinberger, T. E., & Ocker, L. J. (2022). Mood Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003099062-21
49. Benatmane, M., Benhabiles, S., Machane, R., Hammal, K., & Sinaceur, S. (2014). La dépression peut mimer n’importe quelle maladie : à propos d’un cas clinique. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.241
50. Bentes, C., & Pimentel, J. G. (2012). Estado de mal convulsivo. Aspectos fisiopatológicos e clínicos.. Acta Médica Portuguesa. https://doi.org/10.20344/amp.1154
51. Bentham, A. M. P., McKay, A., Quemada, I., Clare, L., Eastwood, N., & McKenna, P. J. (1996). Delusions in Schizophrenia: A Phenomenological and Psychological Exploration. Cognitive Neuropsychiatry. https://doi.org/10.1080/135468096396451
52. Berg, A. T. (2011). Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02905.x
53. Berg, J., & Grimeland, J. (2012). Obsessive-compulsive disorder in disguise—Case report. Open Journal of Psychiatry. https://doi.org/10.4236/ojpsych.2012.23026
54. Besag, F., Gobbi, G., Aldenkamp, A. P., Caplan, R., Dunn, D. W., & Sillanpää, M. (2016). Psychiatric and Behavioural Disorders in Children with Epilepsy (ILAE Task Force Report): Subtle behavioural and cognitive manifestations of epilepsy. Epileptic Disorders. https://doi.org/10.1684/epd.2016.0816
55. Bhat, M. (1996). Outcome of rehabilitation programme: Is there a differential response?. European Psychiatry. https://doi.org/10.1016/0924-9338(96)88851-1
56. Biggs, Q. M., Guimond, J. M., Fullerton, C. S., Ursano, R. J., Gray, C. L., Goldenberg, M., Reissman, D. B., McCarroll, J. E., Santiago, P. N., & Tyler, M. P. (2012). The Epidemiology of Acute Stress Disorder and Other Early Responses to Trauma in Adults. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195399066.013.0006
57. Billiard, M. (2003). Recurrent hypersomnias. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_33
58. Binbay, Z., Solmaz, M., Aydın, H., Kulacaoğlu, F., Sağır, S., & Lal, B. (2012). P-1214 - Very late onset schizophrenia: a case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75381-6
59. Binetti, G., Magni, E., Padovani, A., Bianchetti, A., & Trabucchi, M. (1996). Executive dysfunction inearly Alzheimer's disease.
60. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
61. Blanco, S., Mitra, S., Howard, C. J., & Sumich, A. (2022). Psychological trauma, mood and social isolation do not explain elevated dissociation in functional neurological disorder (FND). Personality and Individual Differences. https://doi.org/10.1016/j.paid.2022.111952
62. Blay, S. L. (2011). A Case of Major Depressive Disorder and Symptoms of Polycystic Ovary Syndrome Responding to Escitalopram. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01183
63. Bob, P. (2007). Dissociation, forced normalization and dynamic multi-stability of the brain.. PubMed.
64. Bolton, D., & Hill, J. (2004). Psychiatric conditions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198515609.003.0009
65. Bosanac, B., Dominik, P., Gabrić, P., Hrstić, A., Ključarić, D. K., Kužina, I., Sović, M. S., & Vandek, M. (2017). Lexical-semantic categorisation in patients of schizophrenia. https://doi.org/10.5281/zenodo.4681378
66. Bosanac, B., Dominik, P., Gabrić, P., Hrstić, A., Ključarić, D. K., Kužina, I., Sović, M. S., & Vandek, M. (2020). Lexical-semantic categorisation in patients of schizophrenia. https://doi.org/10.17605/osf.io/5z9c4
67. Bourgeois, B. F. D., & Landau, W. M. (2004). Landau–Kleffner syndrome and temporal cortical volume reduction. Neurology. https://doi.org/10.1212/01.wnl.0000143267.68149.c2
68. Boylan, K., & Eppel, A. (2008). The severe mood dysregulation phenotype: case description of a female adolescent.. PubMed.
69. Braconi, L. (1976). Gene Interaction in the Phenotypic Expression of Mental Diseases. Acta geneticae medicae et gemellologiae. https://doi.org/10.1017/s0001566000014197
70. Braconi, L. (1976). Gene Interaction in the Phenotypic Expression of Mental Diseases. Acta geneticae medicae et gemellologiae. https://doi.org/10.1017/s1120962300791116
71. Braitman, D. V., & Bustillo, J. (2020). Schizophrenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198836506.003.0007
72. Bresaly, R., Albokhari, A., Mal, R., Tashkandi, A., Alsawas, A., Abualshamat, M., Harazi, G. A., Alamri, S., Shabekni, A., Alharthi, A. A. M., Alwadai, M., Alluqmani, M., Alsabban, A., Hamza, A. A., & Aladalah, A. S. (2022). Suicidal Attempt in a Schizophrenic Patient with a High Level of Expressed Emotion. International Journal Of Pharmaceutical Research And Allied Sciences. https://doi.org/10.51847/7geaqz0z0k
73. Broniarczyk-Czarniak, M., Sowińska, K., Białas, J., & Talarowska, M. (2019). Ciężka depresja z nasilonymi zaburzeniami funkcji poznawczych czy otępienie.
74. Brook, P. R., & Berrios, G. E. (1985). Delusions and the psychopathology of the elderly with dementia. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1985.tb02610.x
75. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
76. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
77. Buist‐Bouwman, M. A. (2007). Functional limitations associated with mental disorders : inescapable fact or avoidable reality?.
78. Burke, A., Yaari, R., Tariot, P. N., Dougherty, J., Fleisher, A., & Brand, H. (2012). The Shadow People. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12alz01398
79. Bursch, B., & Haskell, R. E. (2016). Factitious Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780190245863.003.0019
80. Byrne, E. J. (1996). The nature of the cognitive decline in Lewy body dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511601187.009
81. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Le trouble hyperkinétique ou déficit de l'attention/hyperactivité. Le point sur... Psychologie.
82. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Les troubles de l'humeur. Le point sur... Psychologie.
83. Campoy, A. T., Rotger, M. Y., Gutiérrez, L. R. D. L. H., & Pastorelli, R. V. (2011). ¿Psicosis mental injertada o retraso mental? A propósito de un caso.. Psiquiatria.com.
84. Carlini, S. V., & Deligiannidis, K. M. (2020). Evidence-Based Treatment of Premenstrual Dysphoric Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.19ac13071
85. Carod-Artal, F. J., Irimia, P., & Ezpeleta, D. (2012). Migraña crónica: definición, epidemiología, factores de riesgo y tratamiento. Revista de Neurología. https://doi.org/10.33588/rn.5410.2012170
86. Cascino, G. D. (2004). Intractable partial epilepsy of left frontal lobe origin related to focal cortical dysplasia. https://doi.org/10.1093/oso/9780195177442.003.0004
87. CASEY, P., & Bailey, S. (2011). Adjustment disorders: the state of the art. World Psychiatry. https://doi.org/10.1002/j.2051-5545.2011.tb00003.x
88. Castle, D., Abel, K. M., Takei, N., & Murray, R. (1995). Gender Differences in Schizophrenia: Hormonal Effect or Subtypes?. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/21.1.1
89. Cha, Y., Baloh, R. W., Cho, C., Magnusson, M., Song, J., Strupp, M., Wuyts, F. L., & Staab, J. P. (2020). Mal de débarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200714
90. Choo, K.-Q., Wl, L., How, C., & Ng, B. (2015). Hoarding in Singapore. Singapore Medical Journal. https://doi.org/10.11622/smedj.2015131
91. Chung, Y. I., & Lee, B. D. (2010). Similarities and Differences between DSM-IV Brief Psychotic Disorder and ICD-10 Acute and Transient Psychotic Disorder. JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION.
92. Citrome, L. (2015). A primer on binge eating disorder diagnosis and management. CNS Spectrums. https://doi.org/10.1017/s1092852915000772
93. Coccaro, E. F. (2012). Intermittent Explosive Disorder as a Disorder of Impulsive Aggression for DSM-5. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2012.11081259
94. Cohen, L. J., & Brody, D. S. (2015). Frontotemporal Dementia‐Like Syndrome Following Recall of Childhood Sexual Abuse. Journal of Traumatic Stress. https://doi.org/10.1002/jts.22016
95. Compton, M. T., & Broussard, B. (2010). Promoting Recovery. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0021
96. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
97. Costa, T., Coenen, V. A., & Döbrössy, M. D. (2023). Neuronal networks of depression: Pushing the limits of brain stimulation technology. Open Access Government. https://doi.org/10.56367/oag-038-10653
98. Crerand, C. E., & Sarwer, D. B. (2010). Body Dysmorphic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy2000
99. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
100. Darnell, R. B., & Posner, J. B. (2010). Cerebral Hemisphere Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199772735.003.004
101. Davidescu, E. I., Tudose, C., Popa, N. L., & Chirila, M. (2015). Frontotemporal Neurocognitive Disorder: a Challenging Diagnosis. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30969-x
102. Davidson, M. (2019). Cognitive impairment as a diagnostic criterion and treatment target in schizophrenia. World Psychiatry. https://doi.org/10.1002/wps.20651
103. Davidson, M., & Weiser, M. (2004). Prodromal Schizophrenia: The Dilemma of Prediction and Early Intervention. CNS Spectrums. https://doi.org/10.1017/s109285290000273x
104. Dehanov, S., & Ferreira, T. (2019). AN IMMACULATE CONCEPTION – THE DIFFERENTIAL DIAGNOSIS OF A DELUSION OF PREGNANCY. https://doi.org/10.26226/morressier.5d1a037857558b317a14085a
105. Delgado, P. L., & Schillerstrom, J. E. (2009). Cognitive Difficulties Associated With Depression What Are the Implications for Treatment.
106. Devanand, D. P. (1999). The Interrelations Between Psychosis, Behavioral Disturbance, and Depression in Alzheimer Disease. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/00002093-199911001-00002
107. Devanand, D. P. (1999). The Interrelations Between Psychosis, Behavioral Disturbance, and Depression in Alzheimer Disease. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/00002093-199911002-00002
108. Diefenbach, G. J., & Goethe, J. W. (2006). Clinical interventions for late-life anxious depression. Clinical Interventions in Aging. https://doi.org/10.2147/ciia.2006.1.1.41
109. Diferiansyah, O., Septa, T., & Lisiswanti, R. (2016). Gangguan Cemas Menyeluruh. Jurnal Medula.
110. Ding, K., Gupta, P. K., & Diaz‐Arrastia, R. (2016). Epilepsy after Traumatic Brain Injury. CRC Press, Taylor and Francis Group eBooks.
111. Divya, M., Preeti, B., & Srihari, S. (2023). EVALUATION OF DHARANIYA VEGA (SUPPRESSIBLE URGES) BY DEVELOPING TOOLS OF ASSESSMENT W.S.R.TO MANODAIHIKA SIDDHANT (PSYCHOSOMATIC CONCEPT) AND ROLE OF SATTVAVAJAY CHIKITSAA IN SUPPRESSION OF DHARANIYA VEGA -A CLINICAL AND ASSESSMENT PROTOCOL. PARIPEX-INDIAN JOURNAL OF RESEARCH. https://doi.org/10.36106/paripex/2510301
112. Djamshidian, A., Pagnier, G., Frank, M. J., & Friedman, J. H. (2022). Impulse Control Disorders and the Dopamine Dysregulation Syndrome. Cambridge University Press eBooks. https://doi.org/10.1017/9781009039291.021
113. Dobrea, C., Dell’Osso, B., Carlotta, M., Cremaschi, L., Arici, C., Benatti, B., & Carlo, A. D. (2012). Neuroimaging Data in Bipolar Disorder: An Updated View. InTech eBooks. https://doi.org/10.5772/24566
114. Donati, F., Carrara, C., Casetta, C., Giudice, R. D., Zalaffi, M., Cornali, M., Maestri, D., Sarasso, S., & D’Agostino, A. (2020). M6. REDUCED READINESS POTENTIAL AS A NEUROPHYSIOLOGICAL CORRELATE OF SELF-DISTURBANCES IN EARLY–COURSE PSYCHOSIS: PRELIMINARY FINDINGS FROM A HIGH–DENSITY EEG STUDY. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaa030.318
115. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
116. Drake, K., & Casher, M. I. (2020). The Inpatient with Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/9781108656672.007
117. Drury, I., Klass, D. W., Westmoreland, B. F., & Sharbrough, F. W. (1985). An acute syndrome with psychiatric symptoms and EEG abnormalities. Neurology. https://doi.org/10.1212/wnl.35.6.911
118. Duarte-Mangas, M., & Matos‐Pires, A. (2019). OBSESSIVE-COMPULSIVE DISORDER PRESENTING AS SCHIZOPHRENIA: A CASE REPORT.. https://doi.org/10.26226/morressier.5d1a037357558b317a1403fb
119. Dubovsky, S., & Thomas, M. P. (1992). Psychotic Depression: Advances in Conceptualization and Treatment. Psychiatric Services. https://doi.org/10.1176/ps.43.12.1189
120. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
121. Dumitrașcu, A., Dumitrescu, C., Chirit, C., Petrova, E., Dumitru, N., Ghemigian, A., Carşote, M., Terzea, D., & Valea, A. (2020). Dyke-Davidoff-Masson syndrome: An endocrine perspective. Romanian Medical Journal. https://doi.org/10.37897/rmj.2020.4.3
122. Dutta, A., Poudel, R., Thapa, L., & Pokhrel, B. (2014). Psychogenic Blindness: A Rare Presentation. Journal of Psychiatrists Association of Nepal. https://doi.org/10.3126/jpan.v2i2.9729
123. D’Souza, R. S., & Hooten, W. M. (2019). Somatic Syndrome Disorders.
124. Ebenezer, I. S. (2015). Affective Disorders 1: Depression. https://doi.org/10.1002/9781118385777.ch6
125. Edinoff, A. N., Wu, N. W., deBoisblanc, C., Feltner, C. O., Norder, M., Tzoneva, V., Kaye, A. M., Cornett, E. M., Kaye, A. D., Viswanath, O., & Urits, I. (2020). Lumateperone for the Treatment of Schizophrenia.. PubMed.
126. Elble, R. J. (2016). The essential tremor syndromes. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000000347
127. Eloraibi, Z. B. M. (2019). Myelin Water Fraction Change In Febrile Seizures.
128. El‐Mallakh, R. S., & Bauer, M. S. (2015). Bipolar (Manic Depressive) Disorders. Psychiatry. https://doi.org/10.1002/9781118753378.ch49
129. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
130. Ensalada, L. H., & Brigham, C. R. (2002). Clinical Update: Chronic Fatigue Syndrome. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2002.janfeb02
131. Ereshefsky, L., Tran-Johnson, T., & Watanabe, M. (1990). Pathophysiologic basis for schizophrenia and the efficacy of antipsychotics.. PubMed.
132. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
133. Espiard, M.-L., Lecardeur, L., Abadie, P., Halbecq, I., & Dollfus, S. (2006). Trastorno perceptivo persistente por alucinógenos después del consumo de psilocibina: un estudio clínico. European psychiatry (Ed Española). https://doi.org/10.1017/s1134066500003738
134. Evi, E., Wiguna, T., & Malik, K. (2021). KOMORBIDITAS GANGGUAN TIDUR PADA ANAK DENGAN GANGGUAN PEMUSATAN PERHATIAN DAN HIPERAKTIVTAS. Jurnal Muara Medika dan Psikologi Klinis. https://doi.org/10.24912/jmmpk.v1i1.12086
135. Falah, K., Attouche, N., Ajaoui, N., & Agoub, M. (2023). PSYCHOSE POST-ICTALE, UNE ENTITE CLINIQUE A CONNAITRE : A PROPOS DUN CAS HOSPITALISE AU CENTRE PSYCHIATRIQUE UNIVERSITAIRE DE CASABLANCA. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/16768
136. Faran, S., Vatine, J., Lazary, A., Ohry, A., Birbaumer, N., & Kotchoubey, B. (2006). Late recovery from permanent traumatic vegetative state heralded by event-related potentials. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2005.076554
137. Fazel, M., Reed, R. V., & Goldring, L. (2012). Post-traumatic stress disorder. BMJ. https://doi.org/10.1136/bmj.e3790
138. Fernández-Egea, E., & Jones, P. B. (2023). Schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/9781911623137.065
139. Ferrari, M., Silva, J. A., Leong, G., & Weinstock, R. (1997). The Role of Mania in the Genesis of Dangerous Delusional Misidentification. Journal of Forensic Sciences. https://doi.org/10.1520/jfs14179j
140. Ferreri, M., Morand, P., Elatki, S., & Nuss, P. (1999). [Dysthymic disorders].. PubMed.
141. Feuerecker, R., Dieterich, M., Eckhardt‐Henn, A., & Becker‐Bense, S. (2015). Nicht-organischer Schwindel. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0034-1385272
142. Fiar, Z., Hroudov, J., & Raboch, J. (2012). Neurotransmission in Mood Disorders. InTech eBooks. https://doi.org/10.5772/31831
143. Filipa, N., & Sergio, S. (2015). Phenomenology of Depression in Alzheimer's Disease. Advances in Alzheimer's disease. https://doi.org/10.3233/978-1-61499-542-5-3
144. Finlayson, R. E. (1989). Recognition and management of dysthymic disorder.. PubMed.
145. Fischer, T., Agar, M., Hosie, A., & Teodorczuk, A. (2020). Unpacking agitation in practice: a call for greater precision. Age and Ageing. https://doi.org/10.1093/ageing/afaa110
146. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
147. Fitten, L. J. (2015). Psychological Frailty in the Aging Patient. Nestlé Nutrition Institute Workshop series. https://doi.org/10.1159/000382060
148. Flaum, M., & Schultz, S. K. (1996). The Core Symptoms of Schizophrenia. Annals of Medicine. https://doi.org/10.3109/07853899608999116
149. Fletcher, P. C. (2003). Functional neuroimaging of schizophrenia: from a genetic predisposition to the emergence of symptoms. Brain. https://doi.org/10.1093/brain/awh113
150. Flor-Henry, P. (1972). Ictal and Interictal Psychiatric Manifestations in Epilepsy: Specific or Non‐Specific? A Critical Review of Some of the Evidence*. Epilepsia. https://doi.org/10.1111/j.1528-1157.1972.tb05162.x
151. Forrest, J., Willis, L., Holm, K., Kwon, M. S., Anderson, M. A., & Foreman, M. D. (2007). Recognizing quiet delirium.. PubMed. https://doi.org/10.1097/01.naj.0000265267.77070.0c
152. Franz, M. R., & Schepank, H. (1997). [Mood disorders. Prevalence and course of unspecified functional disorders from the epidemiologic and psychosomatic viewpoint].. PubMed.
153. Fukushima, A., Kabaya, K., Mihara, T., Nakayama, M., & Murakami, S. (2019). Two Cases of Ménière’s Disease Associated with Persistent Postural-Perceptual Dizziness. Practica Oto-Rhino-Laryngologica. https://doi.org/10.5631/jibirin.113.13
154. Fulda, S. (2011). Idiopathic REM sleep behavior disorder as a long-term predictor of neurodegenerative disorders. The EPMA Journal. https://doi.org/10.1007/s13167-011-0096-8
155. Gahr, M., Hügl, S., & Freudenmann, R. W. (2011). Protracted delirium with Sheehan's syndrome. Acta Neuropsychiatrica. https://doi.org/10.1111/j.1601-5215.2011.00614.x
156. Ganasan, S. (2019). Managing depression in the primary care setting. Journal of Prescribing Practice. https://doi.org/10.12968/jprp.2019.1.8.388
157. Garcia, M. O., Garnica, V. M., López, M. A., Leon, J. R. D., & Marín, S. G. (2017). Somatic-type delusional disorder and comorbidity mood disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.353
158. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
159. Genton, P., & Guerrini, R. (1993). What Differentiates Landau-Kleffner Syndrome From the Syndrome of Continuous Spikes and Waves During Slow Sleep?. Archives of Neurology. https://doi.org/10.1001/archneur.1993.00540100009006
160. Genton, P., Ferlazzo, E., & Thomas, P. (2007). Absence status epilepsy: Delineation of a distinct idiopathic generalized epilepsy syndrome. Epilepsia. https://doi.org/10.1111/j.1528-1167.2007.01467.x
161. Ghosh, R., Lahiri, D., Dubey, S., Ray, B. K., & Benito‐León, J. (2020). Hallucinatory Palinopsia in COVID-19-Induced Posterior Reversible Encephalopathy Syndrome. Journal of Neuro-Ophthalmology. https://doi.org/10.1097/wno.0000000000001135
162. Giacobbe, P., & Flint, A. J. (2007). Pharmacological treatment of poststroke pathological laughing and crying. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.0737
163. Giasuddin, N. A., & Hossain, M. J. (2020). Understanding Obsessive Compulsive Disorder and Management Options. Faridpur Medical College Journal. https://doi.org/10.3329/fmcj.v15i1.49009
164. Gilman, S. E., Breslau, J., Trinh, N., Fava, M., Murphy, J. M., & Smoller, J. W. (2011). Bereavement and the Diagnosis of Major Depressive Episode in the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.10m06080
165. Giotakos, O. (2017). Poor insight and psychosis. Psychiatriki. https://doi.org/10.22365/jpsych.2017.284.332
166. Giotakos, O. (2017). Poor insight in psychosis and meta-representation models. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.26386/obrela.v1i1.5
167. González, M., Pablo, J. D., & Valdés, M. (2003). Delirium: la confusión de los clínicos. Revista médica de Chile. https://doi.org/10.4067/s0034-98872003000900013
168. Goodin, D. S., Frohman, E. M., Garmany, G., Halper, J., Likosky, W., Lublin, F., Silberberg, D. H., Stuart, W. H., & Noort, S. V. D. (2002). Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines: Table 1.. Neurology. https://doi.org/10.1212/wnl.58.2.169
169. Goodwin, G. M. (1997). Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of Psychopharmacology. https://doi.org/10.1177/026988119701100204
170. Gorman, J. M. (1992). NEUROPSYCHIATRIC ASPECTS OF HIV INFECTION. Clinical Neuropharmacology. https://doi.org/10.1097/00002826-199201001-00341
171. Gracias, M. J., & Serra, M. (2012). P-747 - Psychosis - a symptom of multiple scleroses disease, a case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)74914-3
172. Grandner, M. A., & Perlis, M. L. (2015). Treating Insomnia Disorder in the Context of Medical and Psychiatric Comorbidities. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2015.3015
173. Groisman, A. E., & Seminatore, M. L. (2003). Children and Adolescents Who Have Schizophrenia. Pediatrics in Review. https://doi.org/10.1542/pir.24.10.356
174. Gründer, G. (2006). Remission bei Depression erreichen. psychoneuro. https://doi.org/10.1055/s-2006-934199
175. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
176. Gupta, S., Laddha, A., Chaturvedi, P., Chaturvedi, N., Mishra, A., & Raghvendra, R. (2011). Trends and strategy towards therapies for status epilepticus: A decisive review. International Journal of Pharmaceutical Sciences Review and Research.
177. Gur, R. E., & Johnson, A. B. (2006). Understanding the Disorder: What it is and What to Expect. https://doi.org/10.1093/oso/9780195182118.003.0002
178. Gustafson, L. (1996). What is dementia?. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1996.tb00367.x
179. Gómez‐Revuelta, M., Blanco, L. S., Ruíz, M. J., Jenaro, G. P. D. S., Rodríguez, R. L., Olivares, O. P., & Morales, N. N. (2017). A Clinical review about differential diagnosis and comorbidities on premenstrual dysphoric disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.577
180. Hafeza, M. J., Bourjia, H., & Sroura, H. (2020). Functional Neurological Deficit: one of the most controversial diagnosis- case report of a patient with paraplegia. International Journal of Case Reports. https://doi.org/10.28933/ijcr-2020-02-2305
181. Haggard, P., Martin, F., Taylor-Clarke, M., Jeannerod, M., & Franck, N. (2003). Awareness of action in schizophrenia. Neuroreport. https://doi.org/10.1097/00001756-200305230-00035
182. Hainline, B., Gurin, L., & Torres, D. M. (2019). Anxiety Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0016
183. Hainline, B., Gurin, L., & Torres, D. M. (2019). Cognitive Dysfunction Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0034
184. Hainline, B., Gurin, L., & Torres, D. M. (2019). Depression Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0015
185. Hainline, B., Gurin, L., & Torres, D. M. (2019). Migraine and Other Headache Disorders Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0014
186. Hainline, B., Gurin, L., & Torres, D. M. (2019). Unmasking Neuropsychiatric Disorders Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0035
187. Hansell, N. (1975). Sympathomimetics and Schizophrenia. JAMA. https://doi.org/10.1001/jama.1975.03260250012002
188. Hartman, T. O., Lam, C. L. K., Usta, J., Clarke, D. D., Fortes, S., & Dowrick, C. (2018). Addressing the needs of patients with medically unexplained symptoms: 10 key messages. British Journal of General Practice. https://doi.org/10.3399/bjgp18x698813
189. Harvey, A. G. (2006). What about patients who can’t sleep? Case formulation for insomnia. https://doi.org/10.4324/9780203965177-19
190. Harvey, P. D. (2001). Cognitive impairment in elderly patients with schizophrenia: age related changes. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/1099-1166(200112)16:1+<::aid-gps565>3.0.co;2-v
191. Hasanah, L. (2015). Penyakit Skizoafektif dengan Tipe Depresi pada Wanita 34 Tahun. Jurnal Medula.
192. Haslam, R. H. A. (1997). Nonfebrile Seizures. Pediatrics in Review. https://doi.org/10.1542/pir.18.2.39
193. Hassan, M. S., Sidow, N. O., & Mohamed, N. A. (2022). Transient global amnesia: Uncommon diagnosis of exclusion. Clinical Case Reports. https://doi.org/10.1002/ccr3.6533
194. Hawes, D. J., & Scalise, P. (2005). Childhood depression: early risk and resilience and introducing solids to infants. https://doi.org/10.4225/50/5552facc15227
195. Heckers, S. (2009). Neurobiology of Schizophrenia Spectrum Disorders. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.v38n5p431
196. Heilman, K. M., Watson, R. T., & Valenstein, E. (2003). Neglect and Related Disorders. https://doi.org/10.1093/oso/9780195133677.003.0013
197. Heinrichs, R. W. (1993). Schizophrenia and the brain: Conditions for a neuropsychology of madness.. American Psychologist. https://doi.org/10.1037//0003-066x.48.3.221
198. Helbig, K. L., & Goldberg, E. M. (2021). SCN3A- Related Neurodevelopmental Disorder.
199. Henning, A., Kurtom, M., & Espiridion, E. D. (2019). A Case Study of Acute Stimulant-induced Psychosis. Cureus. https://doi.org/10.7759/cureus.4126
200. Henry, T. R., & Moortele, P. V. D. (2009). Seizure disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139193481.036
201. Henríquez, M. R., Gómez, A. H., Balut, F., Hernández, V., & Perfetti, A. J. (2023). Trastorno de sueño inquieto: una nueva entidad clínica a considerar en niños. Andes pediatrica. https://doi.org/10.32641/andespediatr.v94i1.4203
202. Hermans, M. C. E., Faber, C. G., Vanhoutte, E. K., Bakkers, M., Baets, M. H. D., Die‐Smulders, C. D., & Merkies, I. S. J. (2011). Peripheral neuropathy in myotonic dystrophy type 1. Journal of the Peripheral Nervous System. https://doi.org/10.1111/j.1529-8027.2011.00313.x
203. Hidayat, L. S., & Kristiana, I. F. (2023). Religiosity and Mental Health: A Case Study. Proceedings of International Conference on Psychological Studies (ICPsyche). https://doi.org/10.58959/icpsyche.v4i1.59
204. Hirschfeld, R. M. A., Calabrese, J. R., Frye, M. A., Lavori, P. W., Sachs, G., Thase, M. E., & Wagner, K. D. (2007). Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.. PubMed.
205. Hj, A., Barrucand, D., & Auzépy, P. (1993). [Alcohol withdrawal syndrome and delirium tremens. Their treatment].. PubMed.
206. Holloman, L. C., & Marder, S. R. (1997). Management of acute extrapyramidal effects induced by antipsychotic drugs. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/54.21.2461
207. House, J. S. (1987). Chronic stress and chronic disease in life and work: Conceptual and methodological issues. Work & Stress. https://doi.org/10.1080/02678378708258494
208. Huber, M. (1996). [Prognosis of depression].. PubMed.
209. Hussain, E., Momin, A., Islam, M., Haque, S., Hossain, M. A., Chowdhury, R., & Hoque, A. (2016). Lafora Body Disease: A Rare Type of Progressive Myoclonic Epilepsy. American Journal of Medical Case Reports. https://doi.org/10.12691/ajmcr-4-3-2
210. Häfner, H. (2002). Prodrome, onset and early course of schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544118.011
211. Ingram, R. E., Scott, W. D., & Hamill, S. K. (2008). Depression <i>Social and Cognitive Aspects</i>. https://doi.org/10.1093/oso/9780195374216.003.0009
212. Insel, T. R., Zahn, T. P., & Murphy, D. L. (2019). Obsessive-Compulsive Disorder. Routledge eBooks. https://doi.org/10.4324/9780203728215-40
213. Isenberg, K., & Garcia, K. S. (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
214. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
215. Jacome, D. E. (1999). Volitional Monocular Lilliputian Visual Hallucinations and Synesthesia. European Neurology. https://doi.org/10.1159/000008001
216. Jaimes, A., Guerrero, R., González‐Giráldez, B., & Serratosa, J. M. (2020). <i>De novo</i> truncating mutation in <i>SCN1A</i> as a cause of febrile seizures <i>plus</i> (FS+). Epileptic Disorders. https://doi.org/10.1684/epd.2020.1167
217. Jj, D. L. G. M., Francos, D. D., Herrero, H., Al, R. M., & Gómez, L. (1989). [Seasonal variations in dexamethasone suppression test in psychiatric patients].. PubMed.
218. Joshi, R., & Tomar, S. (2012). Effect of optimism/pessimism attitude on depression and coping strategies. Indian Journal of Positive Psychology. https://doi.org/10.15614/ijpp/2012/v3i4/53371
219. Joshi, S., & Kapur, J. (2012). GABAA Receptor Plasticity during Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199746545.003.0041
220. Jung, S. P., & Lee, K. M. (2007). Chronic Fatigue Syndrome. Yeungnam University Journal of Medicine. https://doi.org/10.12701/yujm.2007.24.1.1
221. Juruena, M. F. (2012). Understanding subthreshold depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.009
222. Kaiser, S., Heekeren, K., & Simon, J. J. (2011). The Negative Symptoms of Schizophrenia: Category or Continuum?. Psychopathology. https://doi.org/10.1159/000325912
223. Kakunje, A., & Rao, T. S. (2017). Making sense of the role of sense organs in trichotillomania. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.210740
224. Kamenskiy, I., Kaymovskiy, I. L., Gersamiya, A. G., & Vavilina, I. (2017). Cognitive impairment. The effects of seizures?. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro20171179250-54
225. Kane, J. M. (1996). Schizophrenia. New England Journal of Medicine. https://doi.org/10.1056/nejm199601043340109
226. Karaaslan, K., Gümüş, E., Gülcü, N., & Altunrende, B. (2008). Dirençli Jeneralize Status Epileptikusun Propofol ile Tedavisi (Olgu Sunumu). Duzce Medical Journal.
227. Karakatsoulis, G. N., Tsapakis, E.-M., & Fountoulakis, K. Ν. (2021). Clinical characteristics and treatment of treatment-resistant bipolar depression. Psychiatriki. https://doi.org/10.22365/jpsych.2021.048
228. Karyakina, M., & Rychkova, O. (2021). Cognitive impairments in schizophrenia in foreign studies: single function deficits or group of syndromes?. Journal of Modern Foreign Psychology. https://doi.org/10.17759/jmfp.2021100201
229. Katon, W., & Ries, R. (1983). Schizophrenia.. PubMed.
230. Kemp, S., Goulding, P., Spencer, J., & Mitchell, A. J. (2005). Unusually rapid and severe cognitive deterioration after mild traumatic brain injury. Brain Injury. https://doi.org/10.1080/02699050500309353
231. Kempster, P., Williams, D. R., Selikhova, M., Holton, J., Révész, T., & Lees, A. J. (2007). Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain. https://doi.org/10.1093/brain/awm142
232. Kendler, K. S. (1982). Demography of Paranoid Psychosis (Delusional Disorder). Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1982.04290080012003
233. Kennedy, S. H. (2008). Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.3/shkennedy
234. Kessler, J., Markowitsch, H. J., Huber, M., Kalbe, E., Weber‐Luxenburger, G., & Kock, P. (1997). Massive and persistent anterograde amnesia in the absence of detectable brain damage: Anterograde psychogenic amnesia or gross reduction in sustained effort?. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/01688639708403746
235. Khan, A. Y., Kalia, R., Ide, G. D., & Ghavami, M. (2017). What Are Realistic Treatment Goals? Lingering Symptoms Require You to Evaluate Pharmacotherapy and Offer Psychosocial Interventions. Current psychiatry.
236. Khess, C. R. J., Das, J., Parial, A., Kothari, S., & Joseph, T. (1999). Obsessive Compulsive Disorder with Psychotic Features:-A Phenomenological Study. Hong Kong journal of psychiatry.
237. Kibel, D., Laffont, I., & Liddle, P. F. (1993). The Composition of the Negative Syndrome of Chronic Schizophrenia. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.162.6.744
238. Kim, H. A., Bisdorff, A., Bronstein, A. M., Lempert, T., Rossi-Izquierdo, M., Staab, J. P., Strupp, M., & Kim, J. (2019). Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-190655
239. Kim, S.-H., Park, S.-J., Byun, S.-I., Kim, J., Kim, J.-W., Chung, S.-Y., Hwang, W.-W., & Kim, J.-H. (2006). Relaxation Training for psychogenic tremor patient with anger : A Case Report. The Korean Society of Oriental Neuropsychiatry.
240. Kimball, A. B., & Grossman, S. A. (2017). Syncope And Related Paroxysmal Spells.
241. Klein, A., Moskau, S., Klockgether, T., & Linnebank, M. (2006). Transient global amnesia like episode in a dialysis patient with severe hyperhomocysteinaemia. Aktuelle Neurologie. https://doi.org/10.1055/s-2006-953442
242. Klein, D. F., & Wender, P. H. (2005). Symptoms of Mood Disorders: Recognizing Biological Depression. https://doi.org/10.1093/oso/9780195156133.003.0002
243. Klonoff, P. S., Lamb, D. G., & Henderson, S. W. (1999). Productivity of patients with brain injuries up to 11 years post-discharge from milieu-based Rehabilitation. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/14.1.151a
244. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. DeckerMed Family Medicine. https://doi.org/10.2310/fm.1336
245. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. https://doi.org/10.2310/neuro.1336
246. Kocabaşoğlu, N., Karaçetin, G., Bayar, R., & Demir, T. (2012). A Review of the Etiology Delirium. InTech eBooks. https://doi.org/10.5772/32411
247. Kopelman, M. D., Guinan, E., & Lewis, P. (1995). Delusional memory, confabulation, and frontal lobe dysfunction: A case study in De Clérambault's syndrome. Neurocase. https://doi.org/10.1080/13554799508402348
248. Korff, M. V., & Simon, G. (1996). The Relationship Between Pain and Depression. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000298474
249. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
250. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2006). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b21610-26
251. Kraus, J. E. (1999). Treatment of Kleptomania With Paroxetine. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v60n1116
252. KS, M. C., Nagarajan., K., & Kanagarajan, A. (2023). Insomnia Management Clinical Trials by various Conventional Therapies – A Review. Research Journal of Pharmacy and Technology. https://doi.org/10.52711/0974-360x.2023.00985
253. Kumar, A., & Das, S. (2015). Recurrent Mania: Rare or Common. Journal of Depression & Anxiety. https://doi.org/10.4172/2167-1044.s2-011
254. Kumar, S., & Browne, M. O. (2003). What are the effects of drug treatments for panic disorder?. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.6.2.34
255. Kurita, A., Yonezawa, J., Suzuki, M., Kawaguchi, S., Ito, Y., & Inoue, K. (2004). [Changes in visual event-related potentials and SPECT in dissociative amnesia].. Rinshō shinkeigaku Clinical neurology.
256. Kwak, S., Lee, S.-G., & Choi, W.-J. (2003). A Case of Dissociative amnesia with Conversion disorder -By using psychotherapy-. Journal of Oriental Neuropsychiatry.
257. Köhler, J., & Heilmeyer‐Kohler, H. (2009). P4‐254: Dementia in multiple sclerosis: is it Alzheimer's or a new entity?. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2009.04.619
258. Landazuri, P., Lecumberri, N. L., Bertran, L. V., Farrenburg, M., & Lhatoo, S. D. (2023). How Do I Make an Epilepsy Diagnosis?. Cambridge University Press eBooks. https://doi.org/10.1017/9781009264976.002
259. Latas, M., Jerotić, S., Tiosavljević, D., & Lačković, M. (2023). Separation Anxiety Disorder: Is There a Justification for a Distinct Diagnostic Category?. Mind Brain and Education. https://doi.org/10.1007/978-3-031-33013-1_7
260. Lawrence, T., & Dalton, K. (2019). Premenstrual Syndrome: A New Criminal Defense?. Routledge eBooks. https://doi.org/10.4324/9780429034213-12
261. Lazaro, Y. M., Molina, R. B., Olivares, L., Pérez, A. M., & Mesián, I. (2016). Paraphrenia: Claiming for its diagnosis. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.2151
262. Lee, B., Huang, S., Hsu, W.-Y., & Chiu, N. (2012). Clinical features of delirious mania: a series of five cases and a brief literature review. BMC Psychiatry. https://doi.org/10.1186/1471-244x-12-65
263. Leonchuk, S. L. (2017). Emotional Volitional Defect - Quintessence of Schizophrenia. Acta Psychopathologica. https://doi.org/10.4172/2469-6676.100089
264. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
265. Levy, R. H. (1996). Sedation in Acute and Chronic Agitation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/j.1875-9114.1996.tb03670.x
266. León, M. S. M. D. (2017). Trastorno por déficit de atención con hiperactividad: autorregulación emocional y funciones ejecutivas.
267. Liddle, P. F. (2012). Descriptive clinical features of schizophrenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0072
268. Liebowitz, M. R., Hollander, E., Schneier, F. R., Campeas, R., Fallon, B. A., Welkowitz, L. A., Cloître, M., & Davies, S. (1990). Anxiety and Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199006001-00012
269. Lievre, J. A. L., Schweitzer, R., & Barnard, A. (2011). The subjective experience of negative symptoms : characteristics of emotional withdrawal. Routledge eBooks.
270. Lievre, J. L., Schweitzer, R., & Barnard, A. (2012). The subjective experience of negative symptoms: Characteristics of emotional withdrawal.
271. Lim, S., Wadia, P. M., Armstrong, M. J., Schenck, C. H., & Lang, A. E. (2015). Augmented Restless Legs Syndrome with Marked Hyperkinesias and Impulsive‐Compulsive Behaviors. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12299
272. Lipton, R. B., & Silberstein, S. D. (2015). Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/head.12505_2
273. Liu, S. (2011). Relationship Discussion between Emotional Factors and Chronic Fatigue Syndrome. Liaoning Zhongyiyao Daxue xuebao.
274. Lockhart, P. J. (2001). Fetal alcohol spectrum disorders for mental health professionals - a brief review. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200109000-00007
275. Lombardi, C., Rocchi, R., Montagna, P., Silani, V., & Parati, G. (2009). Obstructive Sleep Apnea Syndrome: A Cause of Acute Delirium. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.27659
276. Louis, E. D., Lynch, T., Ford, B., Bressman, S., & Fahn, S. (1996). Posttraumatic-Delayed Cerebellar Syndrome-Reply. Archives of Neurology. https://doi.org/10.1001/archneur.1996.00550120016004
277. Lysaker, P. H. (2002). Association of Obsessions and Compulsions in Schizophrenia With Neurocognition and Negative Symptoms. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.14.4.449
278. Lysaker, P. H., & Whitney, K. A. (2008). Obsessive–compulsive symptoms in schizophrenia: prevalence, correlates and treatment. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.9.1.99
279. Lysaker, P. H., Bryson, G., Marks, K. A., Greig, T., & Bell, M. D. (2002). Association of Obsessions and Compulsions in Schizophrenia With Neurocognition and Negative Symptoms. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.14.4.449
280. MacDonald, A. W., & Demro, C. (2023). Schizophrenia: Presentation, Affect and Cognition, Pathophysiology and Etiology. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780197542521.003.0014
281. MacGilvray, P., Williams, R., & Dambro, A. (2016). Anxiety Disorders. Family Medicine. https://doi.org/10.1007/978-3-319-04414-9_32
282. Macleod, M. D. (1877). Cases of Insanity in which Impairment or Loss of one or more of the Special Senses seemed the exciting Cause of the Disease. Journal of Mental Science. https://doi.org/10.1017/s0368315x0000061x
283. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
284. Madrigal, J. G. T. (2012). Status epiléptico en emergencias: manejo tradicional y tendencia actual. Revista Médica de Costa Rica y Centroamérica.
285. Mahesh, R., Pandey, D. K., Bhatt, S., & Gautam, B. (2010). Depression Associated Disorders: Comorbidity, eurobiological and eurobehavioural Link.
286. Mahieux, F. (2003). [Hippocampal sclerosis and dementia].. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
287. Maj, M. (2023). Understanding depression beyond the “mind‐body” dichotomy. World Psychiatry. https://doi.org/10.1002/wps.21142
288. Malhotra, B. S., Nain, P., Sidana, J., Gupta, A., & Sharma, S. (2011). Chronic Fatigue Syndrome: A Review. HAL (Le Centre pour la Communication Scientifique Directe).
289. Malm, D., Pantel, J., & Linaker, O. M. (2005). Psychiatric symptoms in alpha‐mannosidosis. Journal of Intellectual Disability Research. https://doi.org/10.1111/j.1365-2788.2005.00765.x
290. Mameniškienė, R., Bast, T., Bentes, C., Canevini, M. P., Dimova, P., Granata, T., Høgenhaven, H., Jakubi, B. J., Marusič, P., Melikyan, G., Michelucci, R., Мukhin, К. Y., Oehl, B., Ragona, F., Rossetti, A. O., Rubboli, G., Schubert‐Bast, S., Stephani, U., Strobel, J., ... Wolf, P. (2011). Clinical course and variability of non-Rasmussen, nonstroke motor and sensory epilepsia partialis continua: A European survey and analysis of 65 cases. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02974.x
291. Manckoundia, P., Soungui, E. N., Tavernier-Vidal, B., & Mourey, F. (2014). Psychomotor disadaptation syndrome. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2014.0450
292. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
293. Manschreck, T. C. (1996). Delusional disorder: the recognition and management of paranoia.. PubMed.
294. Margoles, M. S., & Hach, S. (2019). Reflex Sympathetic Dystrophy. CRC Press eBooks. https://doi.org/10.1201/9780367810979-14
295. Martín, E. S. S., Juanes, J., Montero, R., & Aguiar, C. S. (2012). Demencia frontotemporal asociada al cromosoma 17 y otros síndromes parkinsonianos asociados a demencia. Revista de Neurología. https://doi.org/10.33588/rn.54s04.2012520
296. Martínez‐Castrillo, J. C., Vela, L., Val, J. D., & Alonso‐Cánovas, A. (2011). Nonmotor Disorders and Their Correlation With Dopamine. The Neurologist. https://doi.org/10.1097/nrl.0b013e318239669f
297. Mavrogiorgou, P., Juckel, G., & Bauer, M. (2001). Rezidivierende paranoid-halluzinatorische Psychose nach Beginn einer Hungerkur bei einer Patientin mit Anorexia nervosa. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2001-13932
298. Mazumdar, P., Chaturvedi, S. K., & Gopinath, P. S. (1995). A Comparative Study of Thought Disorder in Acute and Chronic Schizophrenia. Psychopathology. https://doi.org/10.1159/000284921
299. Małyszczak, K., Pawłowski, T., & Tersa, K. (2007). [Acute delusional disorder with dissociative symptoms--case report].. PubMed.
300. McEvoy, J. P., Asuzu, K., Bradford, D. W., Freudenreich, O., & Moyer, K. (2020). Treatment and management of patients with schizophrenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0065
301. McGuire, B. E., & Wraith, A. E. (2000). Legal and psychological aspects of stalking: a review. Journal of Forensic Psychiatry. https://doi.org/10.1080/09585180050142543
302. McIntyre, R. S., Danielle, S., & Soczynska, J. K. (2014). Differentiating cognitive dysfunction from other dimensions of psychopathology in major depressive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199688807.003.0005
303. McKenna, P. J., & Oh, T. M. (2001). Thought disorder as a syndrome in schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544057.003
304. McKenna, P. J., Kane, J. M., & Parrish, K. (1985). Psychotic syndromes in epilepsy. American Journal of Psychiatry. https://doi.org/10.1176/ajp.142.8.895
305. McKenna, P. J., Tamlyn, D., Lund, C. E., Mortimer, A., Hammond, S., & Baddeley, A. (1990). Amnesic syndrome in schizophrenia. Psychological Medicine. https://doi.org/10.1017/s0033291700036667
306. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
307. Melo, R., & Alves, J. (2014). EPA-0499 – Hysterical psychosis. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)77904-0
308. Mester, H. (1975). [Chronic psychogenic urinary retention].. PubMed.
309. Mesulam, M.-M. (1985). Dementia: Its Definition, Differential Diagnosis, and Subtypes. JAMA. https://doi.org/10.1001/jama.1985.03350410125033
310. Mettu, S., Animireddy, D., Kanumuri, P. K., & Muppa, R. (2016). Symptomatic management of a child with cyclic vomiting syndrome. BMJ Case Reports. https://doi.org/10.1136/bcr-2016-216499
311. Metz-Lutz, D. M.-N., Martin, A. D. S., & Ponsot, G. (2003). Continuous spike-and-wave discharges during slow sleep.
312. Meza, E. G. L., Téllez, F. C., Guevara, I. M. A., González-Aragón, M. D. C. F., & Calderón, L. Á. R. (2003). Estado epiléptico no convulsivo asociado a enfermedad de Lafora: presentación de dos casos. Revista de Neurología. https://doi.org/10.33588/rn.3710.2003290
313. Meza, R. M., Schulz, H. J., Correa-Cote, J. C., Rojas, M., Lal, V., & Espay, A. J. (2019). Teaching Video NeuroImages: Slow periodic myoclonus in subacute sclerosing panencephalitis and fulminant Wilson disease. Neurology. https://doi.org/10.1212/wnl.0000000000008206
314. Miettinen, O. S., & Flegel, K. M. (2003). Elementary concepts of medicine: VII. Course of illness: manifestations, complications, outcome. Journal of Evaluation in Clinical Practice. https://doi.org/10.1046/j.1365-2753.2003.00420.x
315. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395
316. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395_update_001
317. Minton, C. A. B., Bruner, S. M., & Morris, C. A. W. (2017). Diagnosis and Treatment of Children and Adolescents. Routledge eBooks. https://doi.org/10.4324/9781315466736-15
318. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Clinical case report on bipolar affective disorder, mania. IP Journal of Paediatrics and Nursing Science. https://doi.org/10.18231/j.ijpns.2022.007
319. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Mental illness vs mental retardation. IP International Journal of Medical Paediatrics and Oncology. https://doi.org/10.18231/j.ijmpo.2022.003
320. Mitchell, A. J., & Mbbs (2007). Understanding Medication Discontinuation in Depression.
321. Mizuno, T., Matsumoto, H., Mita, K., Kogauchi, S., Kiyono, Y., Kosaka, H., & Omata, N. (2019). Psychosis is an extension of mood swings from the perspective of neuronal plasticity impairments. Medical Hypotheses. https://doi.org/10.1016/j.mehy.2019.02.001
322. Moch, S. (2011). Dysthymia: more than "minor".
323. Moch, S. (2011). Dysthymia: more than “minor” depression. South African Pharmaceutical Journal.
324. Montgomery, S., Bebbington, P., Cowen, P. J., Deakin, J., Freeling, P., Hallström, C., Katona, C., King, D. S., Leonard, B., Levine, S., Phanjoo, A. L., Peet, M., Thompson, C. M., & Thompson, C. M. (1993). Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881193007001041
325. Moore, N. C., LeWitt, P. A., & Gershon, S. (1992). Reduction of dyskinesias and psychiatric disability with clozapine over different time courses. Journal of Psychopharmacology. https://doi.org/10.1177/026988119200600407
326. Morrison, M. C. T. (2003). WHIPLASH – WHY THE ARGUMENTS?. Orthopaedic Proceedings.
327. Morylowska-Topolska, J., Ziemiński, R., Molas, A., Gajewski, J., Flis, M., Stelmach, E., & Karakuła‐Juchnowicz, H. (2016). Schizophrenia and anorexia nervosa – reciprocal relationships. A literature review. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/63514
328. Mota, D. C. M., Barbosa, M., Silva, R. R. D., & Ribeiro, L. H. (2020). SÍNDROME DEL OÍDO MUSICAL Y DEPRESIÓN PSICÓTICA: UN CASO DE DOBLE ACTIVIDAD ALUCINATORIA AUDITIVA..
329. Mouta, S., Vaz, I. F., Pires, M., Ramos, S. R., & Figueiredo, D. (2023). What do we know about pseudodementia?. General Psychiatry. https://doi.org/10.1136/gpsych-2022-100939
330. Mucci, V., Sussetto, M., Ranieri, M., Cavuscens, S., Fornos, A. P., & Guinand, N. (2019). [The Mal de Débarquement Syndrome].. PubMed.
331. Munro, A. (1999). ‘Paranoid spectrum’ illnesses which should be included in the category of delusional disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544095.010
332. Mw, H., Eg, G., Hj, B., & Weel, C. V. (1997). [Chronic fatigue syndrome].. PubMed.
333. Myathari, R., Gupta, A., & Bijarnia‐Mahay, S. (2022). Novel mutation in DMN1L gene in child with Landau Kleffner syndrome: a rare association. International Journal of Contemporary Pediatrics. https://doi.org/10.18203/2349-3291.ijcp20222127
334. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
335. Nadkarni, S., Arnedo, V., & Devinsky, O. (2007). Psychosis in epilepsy patients. Epilepsia. https://doi.org/10.1111/j.1528-1167.2007.01394.x
336. Nafiaa, H., Benchikhi, L., & Ouanass, A. (2022). Morphological Abnormalities in Schizophrenia: Systematic Review. SAS Journal of Medicine. https://doi.org/10.36347/sasjm.2022.v08i05.005
337. Nandi, K., Sarkar, S., Bakshi, P., Chandra, A. C., Chakraborty, A., Mondal, S., Biswas, A., Bera, K., Sen, D. J., & Saha, D. (2005). COVID-19 & CO-MORBIDITY: DEMONIC FORCES THAT SUPRESS THE CIVILIZATION. World Journal of Pharmaceutical and life sciences.
338. Naranđa, F. S. (2019). Značaj Empty selle u procjeni funkcije hipofize.
339. Nasrallah, H. A. (2009). Diagnosis 2.0 Are Mental Illnesses Diseases, Disorders, or Syndromes? A Major Challenge for the DSM-V Committees as They Revise the Diagnostic "Bible" of Psychiatric Disorders Is to Determine Whether Mental Illnesses Are Diseases, Disorders, or Syndromes. Current psychiatry.
340. Neary, D. (1999). Classification of the dementias. Reviews in Clinical Gerontology. https://doi.org/10.1017/s0959259899009156
341. Neto, B. P. F. (2009). Catatonia with Left Temporal Lesion on MRI: Crossing Borders. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70960-5
342. Nishino, S., & Fujiki, N. (2006). Animal models for sleep disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511541742.029
343. Nivoli, G., Lorettu, L., Veneto, L. I., Milia, P., Nivoli, L., & Nivoli, A. (2006). Problemi gestionali delle gravi manifestazioni aggressive : Criminalità e spettro dell'umore. https://doi.org/10.1400/91497
344. Ntchana, A. (2022). A Case of Brief Psychotic Disorder: An Unintended Consequence of COVID-19 Virus. American Journal of Biomedical Science & Research. https://doi.org/10.34297/ajbsr.2022.16.002239
345. Ntchana, A. (2022). A Case of Brief Psychotic Disorder: An Unintended Consequence of COVID-19 Virus. Psychology & Psychological Research International Journal. https://doi.org/10.23880/pprij-16000300
346. Núñez, C., Tobón, S., Vinaccia, S., & Sandín, B. (2006). Evaluación y Terapia Psicológica en la Dispepsia Funcional. Terapia psicológica.
347. Ojeda, A. A. A., Li, B., & Patel, R. (2023). Substance-Induced Psychotic Disorder. Psychiatric Annals. https://doi.org/10.3928/00485713-20230314-01
348. Oke, O., Johnson, B. O., Chida, S., Kekere, V., & Azim, S. (2023). Psychosis as a Manifestation of Focal Impaired Awareness Seizure in a Geriatric Patient. Cureus. https://doi.org/10.7759/cureus.41838
349. Okonoda, K. M., & Allagoa, E. L. P. (2020). Compulsive Sexual Behaviors in a Young Male with Social Anxiety Disorder (Social Phobia). Journal of psychiatry.
350. Olmos-López, A., Ibarra-Aguilar, J., Cornelio-Nieto, J. O., Ocaña-Hernández, L. A., Márquez-Amaya, M. A., Luna-López, N. A., Reséndiz-Aparicio, J. C., & Rodríguez‐Leyva, I. (2019). Clinical guideline: status epilepticus in children and adults. DELETED. https://doi.org/10.24875/rmn.m19000031
351. Omar, R. (2016). Mental Disorder or Untreated Pneumonia. Journal of Forensic Biomechanics. https://doi.org/10.4172/2090-2697.1000127
352. Omran, S., Reza, M., Bali, B., & Kazem, M. (2010). A Case Report of A 2.5-Year-Old Girl with Angelman Syndrome (AS). Iranian journal of child neurology.. https://doi.org/10.22037/ijcn.v3i4.1539
353. Operto, F. F., Pastorino, G. M. G., Padovano, C., Scuoppo, C., Vivenzio, V., & Coppola, G. (2020). Psychogenic Seizures in Adolescents: An “Evergreen” Diagnostic Challenge. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.18662/brain/11.3sup1/131
354. Opjordsmoen, S. (1991). [Is there any connection between structural brain changes and schizophrenia?].. PubMed.
355. Oral, T. (2005). Treatment of acute mania.. PubMed.
356. Orsolini, L., Valchera, A., Papanti, D., Vecchiotti, R., & Berardis, D. D. (2016). The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD). European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1060
357. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
358. Otsuka, K., Kato, S., Abe, T., SUGIYAMA, H., Watanabe, Y., Kobayashi, T., & Okajima, Y. (2002). [Classification of long-term clinical course of 'atypical psychosis': a 20-year follow-up study at a medical school hospital].. PubMed.
359. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
360. O’Donnell, C. P. (2009). Towards the difference between neurosis and psychosis.
361. O’Halloran, E., Branagan, A., Canty, N., Michael, O., & Stokes, H. (2019). P407 Conversion disorder: don’t be mistaken, don’t be misled. Abstracts. https://doi.org/10.1136/archdischild-2019-epa.753
362. O’Malley, M. B., & O’Malley, E. B. (2007). Psychophysiological Insomnia. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-042-7_11
363. Pal, A., Parmar, A., & Deep, R. (2016). Repetitive urges to inflict burns: An unusual presentation of impulse control disorder. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.196042
364. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
365. Paprocka, J., Jamroz, E., Szwed-Białożyt, B., Jezela‐Stanek, A., Kopyta, I., & Marszał, E. (2007). Angelman Syndrome Revisited. The Neurologist. https://doi.org/10.1097/01.nrl.0000253067.32759.aa
366. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
367. Parker, R. S. (2012). Chronic Posttraumatic Disorders of Consciousness. CRC Press eBooks. https://doi.org/10.1201/b10562-14
368. Parmeggiani, A., Posar, A., Antolini, C., Scaduto, M. C., Santucci, M., & Giovanardi‐Rossi, P. (2007). Epilepsy in Patients With Pervasive Developmental Disorder Not Otherwise Specified. Journal of Child Neurology. https://doi.org/10.1177/0883073807306265
369. Pasquier, F., & Petit, H. (1997). Frontotemporal Dementia: Its Rediscovery. European Neurology. https://doi.org/10.1159/000112894
370. Patten, S. B. (2015). Major depressive disorder: reification and (maybe) rheostasis. Epidemiology and Psychiatric Sciences. https://doi.org/10.1017/s2045796015000682
371. Paw, H., & Shulman, R. (2014). Management of status epilepticus. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316182673.042
372. Pechnick, R. N., Cunningham, K. A., & Danovitch, I. (2014). Hallucinogen-Related Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg51
373. Perrott, J., & Burry, L. (2015). Has the Drug of Choice for Treating Critical Illness Delirium Been Established?. The Canadian Journal of Hospital Pharmacy. https://doi.org/10.4212/cjhp.v68i5.1494
374. Pincus, J. H., & Tucker, G. (2002). Epilepsy and Behavior. Behavioral Neurology. https://doi.org/10.1093/oso/9780195137811.003.0001
375. Pitchot, W., & Ansseau, M. (1995). [Clinical case of the month. Major depression in a diabetic patient].. PubMed.
376. Pitchot, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2007). [Discontinuation syndrome associated with antidepressants].. RMLG. Revue médicale de Liège.
377. Pizzigallo, E., Racciatti, D., & Vecchiet, J. (1999). Clinical and Pathophysiological Aspects of Chronic Fatigue Syndrome. Journal of Musculoskeletal Pain. https://doi.org/10.1300/j094v07n01_20
378. Poljak, T. H. (2018). "Alzheimer’s dementia ". Hospice and Palliative Medicine International Journal. https://doi.org/10.15406/hpmij.2018.02.00084
379. Pompili, M., Lamis, D. A., Andrasik, F., & Martelletti, P. (2020). Headache and psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198724322.003.0052
380. Pontius, A. A. (1993). Neuropsychiatric Update of the Crime “Profile” and “Signature” in Single or Serial Homicides: Rule out Limbic Psychotic Trigger Reaction<sup>1</sup>. Psychological Reports. https://doi.org/10.1177/00332941930733pt125
381. Popa, T., & Delcea, C. (2019). Voyeurism and Scopophilia. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.121
382. Porter, R., & Penry, J. K. (1983). Petit mal status.. PubMed.
383. Pozzoli, S., Altamura, A. C., & Bosi, M. (2006). Il trattamento a lungo termine della Depressione Unipolare: focus sulla terapia con Venlafaxina RP. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
384. Praag, H. M. V. (1978). [Comments on the impossible concept of schizophrenia (author's transl)].. PubMed.
385. Praag, H. M. V. (2004). The Debit Balance of Present Day Stress Research. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622970410029928
386. Praag, H. M. V., & Korf, J. (1975). Central Monoamine Deficiency in Depressions: Causative or Secondary Phenomenon?<sup>*</sup>. Pharmacopsychiatry. https://doi.org/10.1055/s-0028-1094463
387. Prasad, D., & Manjula, S. (2011). A state of reversed hypoxic encephalopathy following attempted suicidal hanging: a boon. Medicine Science and the Law. https://doi.org/10.1258/msl.2011.010159
388. Prasad, K., Prasad, M., Ramaratnam, S., & Marson, A. G. (2015). Status epilepticus. https://doi.org/10.1002/9781119067344.ch9
389. Prasetya, E. C., Subagyo, R., Mahyuddin, M. H., Haniifah, U., Rafida, M., Hamida, A., Ramzy, M., & Prasetya, M. T. (2022). Continuously Paranoid Schizophrenia in Young Man: A Case Report. Asian Australasian Neuro and Health Science Journal (AANHS-J). https://doi.org/10.32734/aanhsj.v4i2.9165
390. Praško, J., Herman, E., Raszka, M., Hovorka, J., & Doubek, P. (2007). Disociativní poruchy a jejich léčba. Medicína pro praxi.
391. Praško, J., Raszka, M., & Pastucha, P. (2009). Dissociative Disorders - Clinical Manifestation and Management. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70376-1
392. Premkumar, P., & Sharma, T. (2005). Neuropsychologic functioning and structural MRI of the brain in patients with schizophrenia. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.5.1.85
393. Pridmore, S. (2019). Mood and affect. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.12836
394. Prigatano, G. P., Hendin, B., & Heiserman, J. E. (2014). Denial or unawareness of cognitive deficit associated with multiple sclerosis? A case report. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2014.890700
395. Putra, H. G. S. A. (2015). GANGGUAN AFEKTIF BIPOLAR MANIA DENGAN PSIKOTIK: SEBUAH LAPORAN KASUS. DOAJ (DOAJ: Directory of Open Access Journals).
396. Pérez, P. S. (2015). El déficit cognitivo en el síndrome de fatiga crónica: factores asociados y evolución.
397. Pérez, Á. M. S., Granados, F. J. V., Salazar, M. H., Méndez, A. Z., & Dávalos, É. M. (2005). Síndrome prefrontal ventromedial. Reporte de caso. Neurología, Neurocirugía y Psiquiatría.
398. Pérez-Martínez, D. A., Berbel‐García, Á., Puente-Muñoz, A. I., Díaz, R. A. S., Toledo, M. D., Porta‐Etessam, J., & Martínez‐Salio, A. (1999). Cefalea hípnica: un nuevo caso. Revista de Neurología. https://doi.org/10.33588/rn.2809.99038
399. Quoniam, N. (2007). L'apathie dans la maladie d'Alzheimer et la démence fronto-temporale.
400. Rachmani, S., & Mayasari, D. (2017). Kombinasi Farmakoterapi dan Psikoterapi Pada Pengobatan Episode Depresif Sedang Dengan Gejala Somatis. Jurnal Medula.
401. Radmanović, M. B., & Burgić, S.-S. (2020). Comorbidity in Children and Adolescents with ADHD. IntechOpen eBooks. https://doi.org/10.5772/intechopen.94527
402. Ramasamy, J., Arumugam, S., & Thamizh, J. S. (2014). Atypical Delusional Content in a Case of Persistent Delusional Disorder: Freud Revisited. Indian Journal of Psychological Medicine. https://doi.org/10.4103/0253-7176.140742
403. Ramos, M. F., Uribe, M. O., & Sotres, J. C. (2003). Comparación entre el tratamiento continuo y el intermitente con citalopram para el trastorno disfórico premenstrual. Salud Mental.
404. Reichenberg, L. W., & Seligman, L. (2016). Bipolar and Related Disorders. https://doi.org/10.1002/9781394259465.ch4
405. Reichenberg, L. W., & Seligman, L. (2016). Dissociative Disorders. https://doi.org/10.1002/9781394259465.ch9
406. Reichenberg, L. W., & Seligman, L. (2016). Gender Dysphoria. https://doi.org/10.1002/9781394259465.ch15
407. Reichenberg, L. W., & Seligman, L. (2016). Schizophrenia Spectrum and Other Psychotic Disorders. https://doi.org/10.1002/9781394259465.ch3
408. Reid, W. H., Balis, G. U., & Sutton, B. (1997). The treatment of psychiatric disorders : revised for DSM-IV.
409. Remschmidt, H., & Theisen, F. (2012). Early-Onset Schizophrenia1. Neuropsychobiology. https://doi.org/10.1159/000338548
410. Ribeiro, R. T., Pinto, M. M. P., Villa, T. R., Gamba, L. T., Tengan, C. H., & Souza-Carvalho, D. D. (2009). Migrainous infarction as a complication of sporadic hemiplegic migraine in childhood. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2009000500026
411. Rico, B. (2012). Finding a druggable target for schizophrenia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1209389109
412. Ristić, A. J., Petrović, I., Vojvodić, N., Janković, S., & Sokić, D. (2004). Phenomenology and psychiatric origin of psychogenic nonepileptic seizures. Srpski arhiv za celokupno lekarstvo. https://doi.org/10.2298/sarh0402022r
413. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
414. Robinson, C. P., & Hocker, S. E. (2019). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190862923.003.0098
415. Rodrigues, F. D. A. A. (2022). WHAT HAPPENS IN THE BRAIN OF A PERSON WITH DISORDER. International Journal of Health Science. https://doi.org/10.22533/at.ed.1592442202087
416. Rodríguez, M. R., Nuevo, R., Chatterji, S., & Ayuso‐Mateos, J. L. (2012). Definitions and factors associated with subthreshold depressive conditions: a systematic review. BMC Psychiatry. https://doi.org/10.1186/1471-244x-12-181
417. Rogers, N. L., & Kloss, J. D. (2004). Medical Conditions and Diseases. CRC Press eBooks. https://doi.org/10.3109/9780203998007-6
418. Rosebush, P. I., & Mazurek, M. F. (2007). Catatonia. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-960-8_8
419. Roselló, A. P. (2005). Psicosis posparto y evolución clínica. Estudio de seguimiento hasta 10 años. A propósito de dos casos. Anales de psiquiatría.
420. Rosenblat, J. D., Kurdyak, P., Cosci, F., Berk, M., Maes, M., Brunoni, A. R., Li, M., Rodin, G., McIntyre, R. S., & Carvalho, A. F. (2019). Depression in the medically ill. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867419888576
421. Ross, J. L., & Gowers, S. (2011). Body dysmorphic disorder. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.bp.109.007716
422. Rowe, J. B. (2010). Conversion disorder: understanding the pathogenic links between emotion and motor systems in the brain. Brain. https://doi.org/10.1093/brain/awq096
423. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
424. Roy‐Byrne, P. (1996). Fluoxetine of No Benefit in Chronic Fatigue Syndrome. Journal watch. https://doi.org/10.1056/jp199606010000006
425. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
426. Ryall, R. W. (1989). Affective and manic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511526923.013
427. Rzeszut, M., & Assael, R. (2020). Differentiating Depression From Demoralization in Organ Transplantation Recipients. Progress in Transplantation. https://doi.org/10.1177/1526924820978602
428. Rüstemova, D., Genç, A., Bora, G., & Tur, B. S. (2017). A thermal dysregulation problem after breast cancer surgery; what could be?. Medicine. https://doi.org/10.1097/md.0000000000007027
429. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
430. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
431. Salam, A., Quddus, M. R., & Sheikh, M. S. R. (2015). Epilepsia partialis continua. Bangladesh Medical Journal Khulna. https://doi.org/10.3329/bmjk.v47i1-2.22559
432. Salankar, N., Ahuja, N. J., Chaurasia, S., & Singh, N. (2017). Fuzzy Logic Based Approach for Automation of Emotion Detection in Misophonia. International Journal of Computer Science and Information Technology. https://doi.org/10.5121/ijcsit.2017.9104
433. Sanchinel, A. A. S., & Rubí, W. M. (2019). Aura visual típica sin cefalea: a propósito de un caso. Revista de la Facultad de Ciencias Médicas de Córdoba. https://doi.org/10.31053/1853.0605.v76.n4.25068
434. Sansone, R. A., & Sansone, L. A. (1996). Dysthymic disorder. Postgraduate Medicine. https://doi.org/10.1080/00325481.1996.11946147
435. Sarkar, S., & Dinesh, M. (2023). The threshold problem of impairment criteria in psychiatric diagnosis. Journal of SAARC Psychiatric Federation. https://doi.org/10.4103/jspf.jspf_12_23
436. Scarpino, M., Lanzo, G., Chelazzi, C., Maiorelli, A., Bessi, V., Focardi, M., Lolli, F., & Grippo, A. (2022). Multiple Electroencephalogram Recordings for Monitoring the Evolution of Neurological Complications during Baclofen Withdrawal Syndrome. Case Reports in Critical Care. https://doi.org/10.1155/2022/4245667
437. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
438. Schildkrout, B. (2014). Delusional Thought Content. https://doi.org/10.1002/9781394260447.ch7
439. Schildkrout, B. (2014). Dementia. https://doi.org/10.1002/9781394260447.ch12
440. Schildkrout, B. (2014). Disease #15: Dementia with Lewy Bodies. https://doi.org/10.1002/9781394260447.ch43
441. Schildkrout, B. (2014). Disease #53: Postconcussion Syndrome. https://doi.org/10.1002/9781394260447.ch81
442. Schildkrout, B. (2014). Mood, Affect, and Emotion. https://doi.org/10.1002/9781394260447.ch4
443. Schmidtke, K., Metternich, B., & Hull, M. (2007). Therapy of non-organic memory disorder. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-987738
444. Schott, J. M. (2020). Alzheimer’s disease and other dementias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0574
445. Schweitzer, J. B. (2010). Attention‐Deficit/Hyperactivity Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0096
446. Segal, B. M. (1976). Dysthymia: an Atypical Protracted Depression. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000286999
447. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
448. Selwood, L. (2015). Adherence in schizophrenia. Mental Health Matters.
449. Sen, A., & Johnson, M. R. (2020). Epilepsy in later childhood and adulthood. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0575
450. Serrano, J. L., Vila, S., Vidal, R. C., Padilla, E. B., Lamora, N. S., Mollà, L., Rodríguez, A. M., & López, L. M. M. (2017). COMORBILIDAD ENTRE DEPRESIÓN Y CONDUCTAS IMPULSIVAS: UN CASO DE URGENCIA NEGATIVA.
451. Shail, M. S. (2017). Neuropsychiatry in Demyelination Disease: Using Depression as a Prodrome for Early Diagnosis and Treatment of Multiple Sclerosis. Cureus. https://doi.org/10.7759/cureus.1813
452. Sharma, A., Sorrell, J. H., & Peralta, N. R. (2007). A Protracted Case of Psychosis, Motor Abnormalities, and Agitation. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0211d
453. Shejekar, S., Nemlekar, S., & Srivastava, A. (2019). Organic mood disorder: Sequelae of small vessel disease. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_357_18
454. Sherchan, S., & Joshi, D. (2015). The Man Behind the Royal Massacre. Journal of Nepal Medical Association. https://doi.org/10.31729/jnma.2749
455. Siddiqui, J. A., Qureshi, S. F., & Ghamdi, A. K. A. (2017). Alien Abductions: A Case of Sleep Paralysis. Sleep and Hypnosis. https://doi.org/10.5350/sleep.hypn.2017.19.0144
456. Silva, N. D., Singhapathirana, S., & Silva, C. E. D. (2019). Miller Fisher Syndrome presenting as unilateral abducens nerve palsy: A case report. Research Square (Research Square). https://doi.org/10.21203/rs.2.9144/v1
457. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
458. Singh, G., & Kaur, P. (2017). ANTIPSCYHOTIC INDIAN HERBAL FORMULATIONS: AN OVERVIEW. Indian Research Journal of Pharmacy and Science. https://doi.org/10.21276/irjps.2017.4.1.6
459. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
460. Sinha, S., Moss, A. J., & Calkins, H. (2007). The etiology of sudden death. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544828.014
461. Smorag, U., Matthias, N., Fischer, M., Gehrke, A., & Küther, G. (2006). Auftreten seltener psychosomatischer Störungen in der fachübergreifenden Früh-Rehabilitation. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. https://doi.org/10.1055/s-2006-954388
462. Solmi, M., Bortolato, B., Veronese, N., Stubbs, B., Herrmann, N., & Carvalho, A. F. (2019). Pharmacological Interventions for Cognitive Dysfunction in Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0018
463. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
464. Sommer, I. E., Koops, S., & Blom, J. D. (2012). Comparison of auditory hallucinations across different disorders and syndromes. Neuropsychiatry. https://doi.org/10.2217/npy.12.2
465. Spence, S. A. (2006). All in the mind? The neural correlates of unexplained physical symptoms. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.12.5.349
466. Squire, L. R. (1989). Amnesia. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4899-6768-8_5
467. Steil, R., Gutermann, J., Harrison, O., Starck, A., Schwartzkopff, L., Schouler‐Ocak, M., & Stangier, U. (2019). Prevalence of prolonged grief disorder in a sample of female refugees. BMC Psychiatry. https://doi.org/10.1186/s12888-019-2136-1
468. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
469. Stone, W. S., Faraone, S. V., & Tsuang, M. T. (2020). Schizoaffective and schizotypal disorders/acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0061
470. Strain, J. J., Klipstein, K., & Newcorn, J. H. (2008). Adjustment Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch81
471. Strassnig, M., & Harvey, P. D. (2019). Cognition in Schizophrenia Spectrum and Other Psychotic Disorders. https://doi.org/10.1093/oxfordhb/9780190664121.013.14
472. Stringer, S., Nieman, D. H., Kahn, R. S., & Derks, E. M. (2015). Genome-wide association analysis in schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781107337459.010
473. Suranyi-Cadotte, B. E., & Yassa, R. (1993). Clinical Characteristics of Late-onset Schizophrenia and Delusional Disorder. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/19.4.701
474. Suzuki, M. (2019). Schizophrenia: What determines its clinical features and course?. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.12811
475. Suárez, A. L. Á. (2022). Evaluación del efecto antidepresivo del secretoma derivado de células madre mesenquimáticas precondicionadas en un modelo animal de trastorno depresivo mayor. https://doi.org/10.52611/11447/6617
476. Swartz, C. M. (1995). Tardive Psychopathology. Neuropsychobiology. https://doi.org/10.1159/000119222
477. Szerman, N., Ferre, F., Basurte-Villamor, I., Vega, P., Mesías, B., Marín-Navarrete, R., & Arango, C. (2020). Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience Perspective. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2020.589155
478. Sánchez, A. C. (2022). A Nightmare’s Lullaby: Exploring the concept and relevance of oneiroid cyclic psychosis through a clinical case and review. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1827
479. Tabbane, K., Triki, R., Hajeri, S., Johnson, I., & Chérif, W. (2012). P-1319 - Prodromal symptoms of schizophrenia: a retrospective tunisian study. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75486-x
480. Takami, T. (2019). Two Cases of the Fluent Disorder that Became Milder by Remedy for Fluvoxamine Long Term. viXra.
481. Talasman, A. A., Ionescu, C. G., Manea, M. M., & Tuță, S. (2019). Somatic delusional disorder in a patient with idiopathic normal pressure hydrocephalus. Romanian Journal of Psychiatry & Psychotherapy. https://doi.org/10.37897/rjpp.2019.3.7
482. Talasman, A.-A., & Dolfi, A. (2018). Differential diagnosis: delusional disorder- somatic type vs anorexia nervosa. Romanian Journal of Psychiatry & Psychotherapy. https://doi.org/10.37897/rjpp.2018.2.9
483. Talpalar, A. E. (2007). Síndrome neurológico de alta presión. Revista de Neurología. https://doi.org/10.33588/rn.4510.2007401
484. Tanaka, M., Tajima, S., Mizuno, K., Ishii, A., Konishi, Y., Miike, T., & Watanabe, Y. (2015). Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder. The Journal of Physiological Sciences. https://doi.org/10.1007/s12576-015-0399-y
485. Tariq, F. (2012). Premature Ejaculation Re-Visited: Definition and Contemporary Management Approaches. InTech eBooks. https://doi.org/10.5772/25670
486. Tatsuzawa, Y., Ono, Y., Takahashi, T., Yoshino, A., & Nomura, S. (2011). Case of isolated adrenocorticotropic hormone deficiency mimicking major depressive disorder. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2011.02207.x
487. Taylor, M. A. (1999). Bipolar Mood Disorders. https://doi.org/10.1093/oso/9780195130379.003.0008
488. Taylor, M. A. (1999). Personality And Personality Disorders. https://doi.org/10.1093/oso/9780195130379.003.0006
489. Taylor, M. A. (1999). Psychosis. https://doi.org/10.1093/oso/9780195130379.003.0009
490. Tedyanto, E. H., Adnyana, I. M. O., & Widyadharma, I. P. E. (2023). Tension-type Headache and Migraine as Manifestations of Chronic Post-Traumatic Headache. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v50i2.528
491. Teja, N., Gummadi, O. D., Devi, B. V., & Pavani, N. (2020). Evaluation of Depressant Activity on Mansoa alliacea on Rats. Acta Scientific Pharmaceutical Sciences. https://doi.org/10.31080/asps.2020.04.0617
492. Thimm, A., & Bellon, M. (2011). The psychosocial effects of psychogenic non-epileptic seizures (PNES).
493. Thomas, P. (2007). Post-stroke delusion. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544880.026
494. Thompson, W., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller‐Lissner, S. (1999). Functional bowel disorders and functional abdominal pain. Gut. https://doi.org/10.1136/gut.45.2008.ii43
495. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
496. Tollefson, G. D., Souêtre, E., Thomander, L., & Potvin, J. H. (1993). Comorbid anxious signs and symptoms in major depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00013
497. Tomaz, B. C. A., Costallat, G. L., & Henna, E. (2017). Prolonged Hypomanic, Five Years Running Wild: Case Report. SM Journal of Depression Research and Treatment. https://doi.org/10.36876/smjdrt.1014
498. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
499. Torry, Z. D., & Weiss, K. J. (2012). Medication Noncompliance and Criminal Responsibility: Is the Insanity Defense Legitimate?. SSRN Electronic Journal.
500. Torry, Z. D., & Weiss, K. J. (2012). Medication Noncompliance and Criminal Responsibility: Is the Insanity Defense Legitimate?. The Journal of Psychiatry & Law. https://doi.org/10.1177/009318531204000208
501. Toudou‐Daouda, M., Assadeck, H., Obenda, N. S., & Souirti, Z. (2017). Céphalées épileptiques isolées : revue de la littérature. Isolated epileptic headache : review. African & Middle East Epilepsy Journal.
502. Treiman, D. M. (1996). Status epilepticus.. PubMed.
503. Trisnawati, S. Y., Gde, P. S. D. P., Kurniawan, L. S., Goller, A. A. C., & Dewi, V. T. (2022). GEJALA PSIKOTIK PADA PENYAKIT PARKINSON: SEBUAH LAPORAN KASUS DAN TINJAUAN PUSTAKA. Callosum Neurology. https://doi.org/10.29342/cnj.v4i2.152
504. Tw, M. (1985). Recognition of pseudodementia.. PubMed.
505. Uppal, T., Amarasekara, C., & Kaushik, V. (2011). Chronic pelvic pain. Australasian Journal of Ultrasound in Medicine. https://doi.org/10.1002/j.2205-0140.2011.tb00182.x
506. Utari, F. P., Suyanti, T. S., & Karyawati, T. (2023). Asuhan Keperawatan Jiwa Pada Tn.M Dengan Masalah Utama Resiko Perilaku Kekerasan Akibat : Skizofrenia Tak Terinci Di Ruang Srikandi RSJD Dr.Amino Gondohutomo Provinsi Jawa Tengah. DIAGNOSA Jurnal Ilmu Kesehatan dan Keperawatan. https://doi.org/10.59581/diagnosa-widyakarya.v1i4.1305
507. VANVALKENBURG, C., Lilienfeld, S. O., & Akiskal, H. S. (1987). The impact of familial personality disorder and alcoholism on the clinical features of depression. Psychiatry and Psychobiology. https://doi.org/10.1017/s0767399x00004284
508. Veale, D. (2004). Body dysmorphic disorder. Postgraduate Medical Journal. https://doi.org/10.1136/pmj.2003.015289
509. Versino, M., Sances, G., Anghileri, E., Colnaghi, S., Albizzati, C., Bono, G., & Cosi, V. (2003). Dizziness and migraine: a causal relationship?. PubMed.
510. Vitiello, B., Zuddas, A., & Masi, G. (2006). Pharmacologic treatment of children and adolescents with attention deficit hyperactivity disorder. CRC Press eBooks. https://doi.org/10.1201/b14454-11
511. Vásquez-Márquez, I., & Castellanos-Olivares, A. (2011). Delirio postoperatorio en el paciente geriátrico. Deleted Journal.
512. Waddington, J. L., & Youssef, H. A. (1986). An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms. American Journal of Psychiatry. https://doi.org/10.1176/ajp.143.9.1162
513. Waddington, J. L., & Youssef, H. A. (1986). Late Onset Involuntary Movements in Chronic Schizophrenia: Relationship of ‘Tardive’ Dyskinesia to Intellectual Impairment and Negative Symptoms. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.149.5.616
514. Waddington, J. L., & Youssef, H. A. (1996). Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine. https://doi.org/10.1017/s0033291700037697
515. Wahyuni, A. A. S., WIGUNA, I. G. R. P., & Aditya, M. R. (2023). WAHAM SOMATIK : SEBUAH TINJAUAN PUSTAKA. Jurnal Hasil Penelitian dan Pengembangan (JHPP). https://doi.org/10.61116/jhpp.v1i3.156
516. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
517. Walker, M. C., & Sander, J. W. (2011). Epilepsy and Sleep Disorders. CRC Press eBooks. https://doi.org/10.1201/b13388-13
518. Walker, M. C., Cockerell, O., & Sander, J. W. (1996). Non-Convulsive Status Epilepticus Presenting as a Psychiatric Condition. Journal of the Royal Society of Medicine. https://doi.org/10.1177/014107689608900209
519. Wanigasinghe, J., Mettananda, S., & Arachchi, D. K. (2011). A case of Kleine-Levin syndrome. Ceylon Medical Journal. https://doi.org/10.4038/cmj.v56i3.3611
520. Waters, F., Blom, J. D., Jardri, R., Hugdahl, K., & Sommer, I. E. (2017). Auditory hallucinations, not necessarily a hallmark of psychotic disorder. Psychological Medicine. https://doi.org/10.1017/s0033291717002203
521. Weber, P., Vepřeková, B., & Kadaňka, Z. (2009). Psychiatrická problematika v intenzivní medicíně vyššího věku.
522. Weisholtz, D. S., & Dworetzky, B. A. (2014). Epilepsy and Psychosis.
523. Wentzlaff, S., Knauss, J., & Mohr, S. (2012). Fallbericht: Dementia Pugilistica (D.P.) bzw. chronisch traumatische Encephalopathie. Zeitschrift für Neuropsychologie. https://doi.org/10.1024/1016-264x/a000069
524. Wilkinson, M., & Blau, J. (1985). Are Classical and Common Migraine Different Entities?. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.1985.hed2504211.x
525. Willner, P. (1984). Drugs, Biochemistry, and Conscious Experience: Toward a Theory of Psychopharmacology. Perspectives in biology and medicine. https://doi.org/10.1353/pbm.1984.0009
526. Winner, J. G. (2012). Overwhelmed by Side Effects. Current psychiatry.
527. Winokur, G. (1970). Genetic Findings and Methodological Considerations in Manic Depressive Disease. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000193237
528. Wulandari, A., Kusuma, M. D., & Pancarani, R. (2023). Bipolar disorder - difficulties in managing emotional ups and down in an entertainer life: a case report. https://doi.org/10.35990/amhs.v1n3.p137-143
529. Yadav, N. (2005). TODAY’S ERA: THE HEALTH BEHAVIOR AND RISK FACTORS WITH DEPRESSION. World Journal of Advance Healthcare Research.
530. Yaluğ, İ., Tufan, A. E., & Özten, E. (2007). Manic episode due to escitalopram in a patient withepisodic obsessive compulsive disorder: a case report -. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology.
531. Yarlagadda, A. R., Brown, A. B., & Clayton, A. H. (2007). Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611h
532. Yoshimasu, K., Takemura, S., Fukumoto, J., & Miyashit, K. (2012). Self-Reported Symptoms Related to Depression and Suicidal Risk. InTech eBooks. https://doi.org/10.5772/31630
533. Young, J. K., Sukhdeo, S., Advani, S., & Knox, J. (2017). Fugue-Like State and Psychosis in the Context of Chronic Cannabis Use. American Journal of Psychiatry Residents Journal. https://doi.org/10.1176/appi.ajp-rj.2017.120306
534. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
535. Yung, A. R. (2011). Risk, Disorder and Diagnosis. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.3109/00048674.2011.614926
536. Yutzy, S. H. (2015). Somatic Symptom and Related Disorders: Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch62
537. Yılmaz, M., Çıtak, S., & Karamustafalıoğlu, O. (2005). Psychotic disorder due to hypothyroidism: a case report. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology.
538. Zamanian, S., & Rezaei, O. (2015). Comparison of Language Disorders in Psychotic Disorder (Schizophrenia, Bipolar Disorder, Drug-Induced Psychosis). Journal of Psychology Research.
539. Zeuner, K. E., & Gerpen, J. A. V. (2021). Prevalence of Suicidality in Focal and Generalized Dystonia. Neurology. https://doi.org/10.1212/wnl.0000000000011602
540. Ziegler, D. K. (1995). Familial acephaligic migraine. Neurology. https://doi.org/10.1212/wnl.45.12.2293-a
541. Zipursky, R. B., Reilly, T. J., & Murray, R. (2012). The Myth of Schizophrenia as a Progressive Brain Disease. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbs135
542. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
543. Češková, E., Přikryl, R., & Kašpárek, T. (2007). The dynamics of psychopathology in first-episode schizophrenia:1-year follow-up. The World Journal of Biological Psychiatry.